| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucin-1 | 143 | 2024 | 537 | 35.740 |
Why?
|
| Proto-Oncogene Proteins c-abl | 40 | 2008 | 145 | 5.490 |
Why?
|
| Gene Expression Regulation, Neoplastic | 76 | 2024 | 8648 | 4.450 |
Why?
|
| Cytarabine | 68 | 2003 | 695 | 4.110 |
Why?
|
| Tumor Cells, Cultured | 179 | 2020 | 6124 | 3.280 |
Why?
|
| Oncogene Proteins | 14 | 2022 | 717 | 3.200 |
Why?
|
| DNA Damage | 55 | 2023 | 2469 | 3.070 |
Why?
|
| Antigens, Neoplasm | 62 | 2021 | 1996 | 3.070 |
Why?
|
| Apoptosis | 85 | 2019 | 9527 | 2.880 |
Why?
|
| Protein Kinase C | 52 | 2003 | 1207 | 2.850 |
Why?
|
| Cell Line, Tumor | 91 | 2024 | 17142 | 2.750 |
Why?
|
| Leukemia, Myeloid | 42 | 2001 | 693 | 2.270 |
Why?
|
| Tetradecanoylphorbol Acetate | 53 | 2007 | 826 | 2.070 |
Why?
|
| Neoplastic Stem Cells | 13 | 2022 | 1351 | 2.070 |
Why?
|
| Isoenzymes | 25 | 2002 | 1688 | 1.930 |
Why?
|
| Transcription, Genetic | 81 | 2016 | 7609 | 1.930 |
Why?
|
| Protein-Tyrosine Kinases | 30 | 2006 | 2433 | 1.920 |
Why?
|
| Chromatin Assembly and Disassembly | 5 | 2022 | 633 | 1.860 |
Why?
|
| Oleanolic Acid | 9 | 2012 | 43 | 1.810 |
Why?
|
| Dendritic Cells | 41 | 2022 | 2747 | 1.770 |
Why?
|
| Down-Regulation | 33 | 2019 | 2939 | 1.760 |
Why?
|
| Tumor Necrosis Factor-alpha | 65 | 2017 | 4355 | 1.760 |
Why?
|
| Monocytes | 46 | 2001 | 2605 | 1.700 |
Why?
|
| Neoplasms | 70 | 2024 | 22371 | 1.690 |
Why?
|
| Carcinoma, Neuroendocrine | 3 | 2023 | 342 | 1.690 |
Why?
|
| Reactive Oxygen Species | 28 | 2020 | 2152 | 1.680 |
Why?
|
| Peptides | 24 | 2017 | 4354 | 1.660 |
Why?
|
| Proto-Oncogenes | 25 | 1995 | 322 | 1.650 |
Why?
|
| Oxidative Stress | 22 | 2021 | 3140 | 1.650 |
Why?
|
| Cancer Vaccines | 26 | 2022 | 1040 | 1.620 |
Why?
|
| Mucins | 11 | 2009 | 570 | 1.580 |
Why?
|
| Caspases | 21 | 2005 | 882 | 1.570 |
Why?
|
| Cell Survival | 54 | 2018 | 5789 | 1.550 |
Why?
|
| NF-kappa B | 19 | 2024 | 2494 | 1.530 |
Why?
|
| Protein Subunits | 15 | 2017 | 943 | 1.520 |
Why?
|
| Enzyme Activation | 74 | 2013 | 3590 | 1.520 |
Why?
|
| Neuroendocrine Cells | 2 | 2022 | 61 | 1.520 |
Why?
|
| Breast Neoplasms | 92 | 2018 | 21207 | 1.510 |
Why?
|
| Mitogen-Activated Protein Kinases | 17 | 2003 | 1246 | 1.450 |
Why?
|
| Mice, Nude | 45 | 2022 | 3623 | 1.450 |
Why?
|
| Signal Transduction | 70 | 2024 | 23648 | 1.430 |
Why?
|
| Transcription Factors | 42 | 2023 | 12171 | 1.420 |
Why?
|
| Gene Expression Regulation, Leukemic | 17 | 2017 | 658 | 1.410 |
Why?
|
| DNA-Binding Proteins | 49 | 2024 | 9617 | 1.370 |
Why?
|
| src-Family Kinases | 14 | 2007 | 539 | 1.360 |
Why?
|
| Antineoplastic Agents | 56 | 2020 | 13677 | 1.350 |
Why?
|
| Epithelial-Mesenchymal Transition | 8 | 2022 | 757 | 1.280 |
Why?
|
| Amino Acid Sequence | 52 | 2016 | 13422 | 1.280 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 11 | 2023 | 5432 | 1.260 |
Why?
|
| Molecular Sequence Data | 72 | 2015 | 17623 | 1.230 |
Why?
|
| Promoter Regions, Genetic | 36 | 2021 | 5797 | 1.180 |
Why?
|
| Phosphorylation | 58 | 2016 | 8316 | 1.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 14 | 2023 | 2892 | 1.180 |
Why?
|
| Multiple Myeloma | 23 | 2017 | 5196 | 1.150 |
Why?
|
| Protein Binding | 46 | 2021 | 9343 | 1.150 |
Why?
|
| Oxidation-Reduction | 12 | 2021 | 2227 | 1.140 |
Why?
|
| Proto-Oncogene Proteins | 37 | 2014 | 4528 | 1.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 8 | 2024 | 998 | 1.110 |
Why?
|
| Neoplasm Proteins | 21 | 2013 | 3604 | 1.110 |
Why?
|
| Interferon-gamma | 13 | 2022 | 3161 | 1.100 |
Why?
|
| Genes, jun | 16 | 1996 | 69 | 1.100 |
Why?
|
| Leukemia, Myeloid, Acute | 40 | 2021 | 3626 | 1.100 |
Why?
|
| Cell Line | 116 | 2021 | 15602 | 1.080 |
Why?
|
| Transcriptional Activation | 14 | 2017 | 1750 | 1.070 |
Why?
|
| Cell Fusion | 24 | 2012 | 294 | 1.040 |
Why?
|
| Humans | 573 | 2024 | 768171 | 1.040 |
Why?
|
| Carcinoma | 17 | 2020 | 2332 | 1.040 |
Why?
|
| Lung Neoplasms | 28 | 2023 | 13586 | 1.020 |
Why?
|
| Immunoblotting | 25 | 2015 | 1648 | 1.020 |
Why?
|
| Drug Resistance, Neoplasm | 17 | 2023 | 5341 | 1.020 |
Why?
|
| Cell Nucleus | 24 | 2014 | 2885 | 1.020 |
Why?
|
| Cytoskeletal Proteins | 10 | 2004 | 1327 | 0.990 |
Why?
|
| MicroRNAs | 11 | 2024 | 3803 | 0.980 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 12 | 2001 | 492 | 0.980 |
Why?
|
| Mitochondria | 25 | 2012 | 3683 | 0.980 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 16 | 2016 | 1406 | 0.960 |
Why?
|
| Prostatic Neoplasms | 15 | 2023 | 11101 | 0.940 |
Why?
|
| Mice | 174 | 2024 | 82049 | 0.930 |
Why?
|
| Tumor Escape | 2 | 2017 | 372 | 0.920 |
Why?
|
| Immediate-Early Proteins | 17 | 2004 | 444 | 0.920 |
Why?
|
| Protein Structure, Tertiary | 18 | 2015 | 3772 | 0.920 |
Why?
|
| Animals | 231 | 2024 | 169285 | 0.910 |
Why?
|
| Disease Progression | 8 | 2024 | 13668 | 0.890 |
Why?
|
| Cell Differentiation | 68 | 2019 | 11677 | 0.890 |
Why?
|
| Nuclear Proteins | 22 | 2020 | 5804 | 0.890 |
Why?
|
| U937 Cells | 21 | 2009 | 260 | 0.880 |
Why?
|
| Transcription Factor RelA | 5 | 2016 | 253 | 0.880 |
Why?
|
| Colony-Stimulating Factors | 14 | 1991 | 218 | 0.840 |
Why?
|
| Proto-Oncogene Proteins c-jun | 26 | 2017 | 287 | 0.830 |
Why?
|
| Cell Proliferation | 28 | 2020 | 10478 | 0.830 |
Why?
|
| Cytochrome c Group | 14 | 2003 | 123 | 0.830 |
Why?
|
| Transfection | 42 | 2013 | 5756 | 0.830 |
Why?
|
| beta Catenin | 15 | 2016 | 1047 | 0.820 |
Why?
|
| DNA, Neoplasm | 34 | 2006 | 1744 | 0.820 |
Why?
|
| Fusion Proteins, bcr-abl | 6 | 2010 | 430 | 0.810 |
Why?
|
| Trans-Activators | 11 | 2004 | 2857 | 0.800 |
Why?
|
| Gene Expression Regulation | 53 | 2021 | 11930 | 0.800 |
Why?
|
| Glycoproteins | 14 | 2006 | 2202 | 0.780 |
Why?
|
| Acrylamides | 1 | 2023 | 261 | 0.770 |
Why?
|
| Multiprotein Complexes | 3 | 2020 | 1110 | 0.770 |
Why?
|
| Proto-Oncogene Proteins c-akt | 9 | 2023 | 2459 | 0.760 |
Why?
|
| Oligopeptides | 11 | 2018 | 1194 | 0.750 |
Why?
|
| Radiation, Ionizing | 25 | 2010 | 252 | 0.750 |
Why?
|
| Genes, Tumor Suppressor | 7 | 2018 | 1062 | 0.720 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 4 | 2002 | 56 | 0.720 |
Why?
|
| Xenograft Model Antitumor Assays | 16 | 2019 | 3612 | 0.690 |
Why?
|
| Adenocarcinoma | 22 | 2022 | 6395 | 0.690 |
Why?
|
| Antibodies, Monoclonal | 45 | 2020 | 9262 | 0.680 |
Why?
|
| RNA, Messenger | 69 | 2015 | 12801 | 0.680 |
Why?
|
| Tumor Suppressor Protein p53 | 12 | 2020 | 2956 | 0.680 |
Why?
|
| STAT1 Transcription Factor | 3 | 2024 | 343 | 0.670 |
Why?
|
| Isocoumarins | 6 | 2006 | 21 | 0.660 |
Why?
|
| Hydrogen Peroxide | 12 | 2009 | 741 | 0.660 |
Why?
|
| Janus Kinase 1 | 2 | 2011 | 108 | 0.660 |
Why?
|
| Leukemia, Promyelocytic, Acute | 15 | 2005 | 249 | 0.660 |
Why?
|
| RNA, Neoplasm | 40 | 2007 | 749 | 0.650 |
Why?
|
| Macrophage Colony-Stimulating Factor | 12 | 1995 | 186 | 0.650 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2017 | 103 | 0.650 |
Why?
|
| Protein Kinase C-delta | 19 | 2003 | 115 | 0.640 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 724 | 0.640 |
Why?
|
| Pyrimidines | 8 | 2023 | 3048 | 0.640 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 | 2010 | 686 | 0.630 |
Why?
|
| Cell Division | 45 | 2006 | 4477 | 0.630 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 116 | 0.630 |
Why?
|
| Mice, Inbred BALB C | 25 | 2020 | 6231 | 0.620 |
Why?
|
| Carcinoma, Ehrlich Tumor | 2 | 2015 | 23 | 0.610 |
Why?
|
| Piperazines | 13 | 2019 | 2554 | 0.610 |
Why?
|
| Leukemia, Erythroblastic, Acute | 10 | 1989 | 176 | 0.600 |
Why?
|
| RNA, Small Interfering | 15 | 2016 | 3428 | 0.600 |
Why?
|
| Exosomes | 1 | 2023 | 423 | 0.600 |
Why?
|
| Gene Expression Regulation, Enzymologic | 7 | 2013 | 1169 | 0.600 |
Why?
|
| Neuregulin-1 | 4 | 2012 | 136 | 0.600 |
Why?
|
| Spheroids, Cellular | 3 | 2014 | 331 | 0.590 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2022 | 329 | 0.590 |
Why?
|
| Protein Tyrosine Phosphatases | 5 | 2001 | 458 | 0.580 |
Why?
|
| Oncogenes | 11 | 2022 | 1234 | 0.570 |
Why?
|
| Drug Synergism | 20 | 2018 | 1760 | 0.570 |
Why?
|
| Leukemia | 26 | 2004 | 1519 | 0.570 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2022 | 454 | 0.570 |
Why?
|
| Cysteine Endopeptidases | 6 | 2003 | 542 | 0.560 |
Why?
|
| Colorectal Neoplasms | 6 | 2023 | 6975 | 0.560 |
Why?
|
| Peptide Fragments | 24 | 2014 | 5151 | 0.550 |
Why?
|
| Nanocapsules | 2 | 2015 | 95 | 0.550 |
Why?
|
| CDC2 Protein Kinase | 5 | 1996 | 212 | 0.550 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2016 | 2909 | 0.550 |
Why?
|
| Recombinant Fusion Proteins | 30 | 2011 | 3740 | 0.550 |
Why?
|
| Response Elements | 2 | 2016 | 308 | 0.540 |
Why?
|
| Antigens | 4 | 2006 | 1443 | 0.540 |
Why?
|
| Ribonucleosides | 9 | 1990 | 79 | 0.540 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2019 | 2810 | 0.540 |
Why?
|
| Caspase 8 | 6 | 2008 | 198 | 0.530 |
Why?
|
| Phthalazines | 1 | 2019 | 397 | 0.520 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2016 | 40 | 0.520 |
Why?
|
| STAT3 Transcription Factor | 3 | 2017 | 874 | 0.520 |
Why?
|
| Indoles | 2 | 2023 | 1836 | 0.520 |
Why?
|
| MAP Kinase Kinase 4 | 5 | 2005 | 147 | 0.510 |
Why?
|
| Precipitin Tests | 15 | 2004 | 816 | 0.510 |
Why?
|
| Leukemia L1210 | 15 | 1985 | 44 | 0.510 |
Why?
|
| Membrane Glycoproteins | 5 | 2016 | 3713 | 0.510 |
Why?
|
| I-kappa B Kinase | 2 | 2007 | 250 | 0.510 |
Why?
|
| Coumarins | 4 | 2004 | 119 | 0.510 |
Why?
|
| Cystine | 1 | 2016 | 96 | 0.510 |
Why?
|
| Nitrophenols | 1 | 2016 | 169 | 0.510 |
Why?
|
| Immunity, Cellular | 6 | 2019 | 1561 | 0.510 |
Why?
|
| Binding Sites | 23 | 2017 | 6019 | 0.500 |
Why?
|
| Aniline Compounds | 2 | 2023 | 1094 | 0.500 |
Why?
|
| Apoptosis Regulatory Proteins | 9 | 2017 | 1151 | 0.500 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2015 | 252 | 0.500 |
Why?
|
| Cytoplasm | 14 | 2011 | 1505 | 0.500 |
Why?
|
| Antimetabolites, Antineoplastic | 8 | 2002 | 646 | 0.500 |
Why?
|
| Epigenesis, Genetic | 5 | 2023 | 3833 | 0.490 |
Why?
|
| Cell Death | 10 | 2012 | 1680 | 0.490 |
Why?
|
| Cisplatin | 13 | 2020 | 1660 | 0.480 |
Why?
|
| Estrogen Receptor alpha | 5 | 2019 | 581 | 0.480 |
Why?
|
| Receptors, Androgen | 2 | 2012 | 1089 | 0.480 |
Why?
|
| Camptothecin | 8 | 1998 | 600 | 0.480 |
Why?
|
| DNA | 37 | 2017 | 7213 | 0.480 |
Why?
|
| Kinetics | 49 | 2003 | 6330 | 0.480 |
Why?
|
| Recombinant Proteins | 35 | 2006 | 6512 | 0.480 |
Why?
|
| Gene Expression | 30 | 2017 | 7601 | 0.480 |
Why?
|
| Adenoviridae | 20 | 2010 | 1093 | 0.470 |
Why?
|
| Immunoprecipitation | 7 | 2015 | 874 | 0.470 |
Why?
|
| Neoplasms, Experimental | 13 | 2009 | 1230 | 0.470 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 12 | 2005 | 440 | 0.470 |
Why?
|
| Epitopes | 14 | 2011 | 2527 | 0.470 |
Why?
|
| Caspase 3 | 18 | 2010 | 730 | 0.460 |
Why?
|
| DNA Methylation | 4 | 2019 | 4428 | 0.460 |
Why?
|
| Thalidomide | 2 | 2017 | 886 | 0.460 |
Why?
|
| Dexamethasone | 11 | 2008 | 1965 | 0.450 |
Why?
|
| Immunoconjugates | 2 | 2020 | 975 | 0.450 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2013 | 247 | 0.450 |
Why?
|
| Base Sequence | 38 | 2010 | 12422 | 0.450 |
Why?
|
| RNA-Binding Proteins | 4 | 2024 | 1891 | 0.450 |
Why?
|
| Genetic Vectors | 33 | 2017 | 3403 | 0.450 |
Why?
|
| Homeodomain Proteins | 5 | 2020 | 2430 | 0.440 |
Why?
|
| Interleukin-7 | 2 | 2005 | 146 | 0.430 |
Why?
|
| Glutathione | 7 | 2017 | 589 | 0.430 |
Why?
|
| Immune Evasion | 1 | 2017 | 375 | 0.430 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2015 | 4585 | 0.430 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 102 | 0.430 |
Why?
|
| Tyrosine | 13 | 2007 | 1427 | 0.430 |
Why?
|
| Cycloheximide | 22 | 1994 | 341 | 0.420 |
Why?
|
| Phosphoproteins | 4 | 2016 | 2451 | 0.420 |
Why?
|
| Catalase | 2 | 2003 | 215 | 0.420 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2059 | 0.420 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2013 | 146 | 0.420 |
Why?
|
| Interleukin-12 | 8 | 2008 | 577 | 0.420 |
Why?
|
| Lymphocyte Activation | 21 | 2022 | 5505 | 0.420 |
Why?
|
| Amino Acid Motifs | 5 | 2016 | 930 | 0.410 |
Why?
|
| Gene Silencing | 7 | 2017 | 1505 | 0.410 |
Why?
|
| Cyclin D1 | 3 | 2012 | 453 | 0.410 |
Why?
|
| Leukemia, Experimental | 7 | 1992 | 225 | 0.410 |
Why?
|
| Tumor Microenvironment | 8 | 2023 | 3948 | 0.410 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2012 | 23 | 0.400 |
Why?
|
| Protein Biosynthesis | 7 | 2017 | 2094 | 0.400 |
Why?
|
| Neoplasm Transplantation | 31 | 2019 | 2014 | 0.400 |
Why?
|
| Protein Multimerization | 5 | 2017 | 966 | 0.400 |
Why?
|
| cdc25 Phosphatases | 5 | 2014 | 60 | 0.400 |
Why?
|
| Azacitidine | 4 | 2019 | 336 | 0.400 |
Why?
|
| Phosphoric Monoester Hydrolases | 5 | 2017 | 414 | 0.390 |
Why?
|
| Cytotoxins | 1 | 2012 | 154 | 0.390 |
Why?
|
| Cell Cycle | 20 | 2014 | 2934 | 0.390 |
Why?
|
| HCT116 Cells | 7 | 2014 | 405 | 0.390 |
Why?
|
| NADP | 2 | 2015 | 229 | 0.380 |
Why?
|
| bcl-2-Associated X Protein | 3 | 2012 | 281 | 0.380 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2012 | 152 | 0.380 |
Why?
|
| Molecular Targeted Therapy | 6 | 2017 | 2830 | 0.380 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2016 | 1767 | 0.380 |
Why?
|
| Fluorouracil | 12 | 2002 | 1652 | 0.380 |
Why?
|
| Female | 158 | 2022 | 397187 | 0.380 |
Why?
|
| Protein Kinases | 9 | 2002 | 1611 | 0.380 |
Why?
|
| Sulfonamides | 4 | 2016 | 1982 | 0.370 |
Why?
|
| HeLa Cells | 14 | 2009 | 3074 | 0.370 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 1448 | 0.370 |
Why?
|
| bcl-X Protein | 11 | 2009 | 412 | 0.370 |
Why?
|
| Oxidants | 4 | 2005 | 168 | 0.360 |
Why?
|
| Biphenyl Compounds | 1 | 2016 | 1026 | 0.360 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 6 | 2000 | 434 | 0.360 |
Why?
|
| Head and Neck Neoplasms | 3 | 2024 | 2931 | 0.360 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 8 | 2007 | 892 | 0.360 |
Why?
|
| Cadherins | 5 | 2017 | 905 | 0.360 |
Why?
|
| Necrosis | 9 | 2015 | 1616 | 0.360 |
Why?
|
| I-kappa B Proteins | 2 | 2009 | 210 | 0.360 |
Why?
|
| Thymidine | 10 | 1988 | 297 | 0.360 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 1756 | 0.360 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2024 | 286 | 0.350 |
Why?
|
| Viral Proteins | 6 | 2003 | 1802 | 0.350 |
Why?
|
| src Homology Domains | 11 | 2006 | 361 | 0.350 |
Why?
|
| Proteins | 13 | 2000 | 6009 | 0.340 |
Why?
|
| Glutamic Acid | 1 | 2016 | 1191 | 0.340 |
Why?
|
| Phospholipases A | 8 | 1994 | 204 | 0.340 |
Why?
|
| Phosphatidylinositol 3-Kinases | 10 | 2020 | 2885 | 0.340 |
Why?
|
| Mutagens | 4 | 2000 | 181 | 0.340 |
Why?
|
| Vidarabine | 7 | 1989 | 337 | 0.340 |
Why?
|
| Immunotherapy | 13 | 2023 | 4754 | 0.340 |
Why?
|
| Receptor, erbB-2 | 5 | 2014 | 2603 | 0.340 |
Why?
|
| Pyruvate Kinase | 1 | 2011 | 191 | 0.340 |
Why?
|
| Boronic Acids | 1 | 2014 | 915 | 0.340 |
Why?
|
| Disulfides | 1 | 2011 | 466 | 0.330 |
Why?
|
| DNA Replication | 17 | 2000 | 1427 | 0.330 |
Why?
|
| Colonic Neoplasms | 7 | 2020 | 2541 | 0.330 |
Why?
|
| DNA Helicases | 5 | 2020 | 854 | 0.330 |
Why?
|
| Cysteine | 3 | 2011 | 897 | 0.330 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 5 | 2005 | 637 | 0.330 |
Why?
|
| Ethers, Cyclic | 6 | 1994 | 32 | 0.330 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 8 | 1995 | 94 | 0.330 |
Why?
|
| T-Lymphocytes, Cytotoxic | 11 | 2012 | 1801 | 0.330 |
Why?
|
| Caspase 9 | 8 | 2005 | 184 | 0.320 |
Why?
|
| ras Proteins | 1 | 2014 | 1058 | 0.320 |
Why?
|
| Early Growth Response Protein 1 | 19 | 2006 | 133 | 0.320 |
Why?
|
| HEK293 Cells | 5 | 2020 | 4280 | 0.320 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2008 | 43 | 0.320 |
Why?
|
| Mutation | 19 | 2023 | 30237 | 0.310 |
Why?
|
| Drug Resistance | 12 | 1997 | 1599 | 0.310 |
Why?
|
| Gene Expression Profiling | 4 | 2021 | 9540 | 0.310 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2015 | 858 | 0.310 |
Why?
|
| Receptors, Death Domain | 1 | 2008 | 31 | 0.310 |
Why?
|
| Cells, Cultured | 42 | 2012 | 19025 | 0.310 |
Why?
|
| Molecular Weight | 23 | 1995 | 2173 | 0.310 |
Why?
|
| Tamoxifen | 2 | 2013 | 966 | 0.310 |
Why?
|
| Cytotoxicity, Immunologic | 10 | 2011 | 1353 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 362 | 0.310 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 696 | 0.310 |
Why?
|
| Radiation Tolerance | 8 | 2002 | 476 | 0.310 |
Why?
|
| Dimerization | 5 | 2011 | 887 | 0.300 |
Why?
|
| Radioimmunotherapy | 2 | 2008 | 93 | 0.300 |
Why?
|
| Carcinoembryonic Antigen | 7 | 2012 | 338 | 0.300 |
Why?
|
| HSP90 Heat-Shock Proteins | 3 | 2006 | 423 | 0.300 |
Why?
|
| Bismuth | 1 | 2008 | 29 | 0.300 |
Why?
|
| Pyrazines | 1 | 2014 | 1205 | 0.300 |
Why?
|
| Membrane Potential, Mitochondrial | 3 | 2017 | 297 | 0.300 |
Why?
|
| Dimethyl Sulfoxide | 15 | 1991 | 250 | 0.290 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2005 | 414 | 0.290 |
Why?
|
| Inflammation | 5 | 2023 | 10873 | 0.290 |
Why?
|
| Spermidine | 7 | 1986 | 63 | 0.290 |
Why?
|
| T-Lymphocytes | 19 | 2021 | 10266 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 12 | 2009 | 2846 | 0.290 |
Why?
|
| Stress, Physiological | 6 | 1999 | 1408 | 0.290 |
Why?
|
| Glycolysis | 1 | 2011 | 837 | 0.290 |
Why?
|
| Androgens | 2 | 2012 | 1281 | 0.290 |
Why?
|
| Flow Cytometry | 19 | 2015 | 5902 | 0.290 |
Why?
|
| Pancreatic Neoplasms | 3 | 2022 | 5442 | 0.290 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 2004 | 93 | 0.290 |
Why?
|
| Doxorubicin | 5 | 2012 | 2234 | 0.280 |
Why?
|
| Ribavirin | 4 | 1990 | 395 | 0.280 |
Why?
|
| Preleukemia | 6 | 1986 | 34 | 0.280 |
Why?
|
| Radiotherapy | 5 | 2009 | 1502 | 0.280 |
Why?
|
| Mammals | 2 | 2023 | 1135 | 0.270 |
Why?
|
| MAP Kinase Signaling System | 2 | 2013 | 1495 | 0.270 |
Why?
|
| Receptors, Estrogen | 3 | 2012 | 2253 | 0.270 |
Why?
|
| Antimitotic Agents | 1 | 2006 | 28 | 0.270 |
Why?
|
| Up-Regulation | 8 | 2017 | 4149 | 0.270 |
Why?
|
| Bone Marrow | 14 | 2017 | 2935 | 0.260 |
Why?
|
| CDC2-CDC28 Kinases | 2 | 1996 | 111 | 0.260 |
Why?
|
| Plasminogen | 6 | 2002 | 144 | 0.260 |
Why?
|
| Ovarian Neoplasms | 12 | 2008 | 4916 | 0.260 |
Why?
|
| Thymidine Kinase | 8 | 1998 | 286 | 0.260 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2006 | 109 | 0.260 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2007 | 165 | 0.260 |
Why?
|
| Blotting, Northern | 14 | 1994 | 1553 | 0.260 |
Why?
|
| Angiogenesis Inhibitors | 5 | 2005 | 2057 | 0.260 |
Why?
|
| Immunophenotyping | 9 | 2016 | 1864 | 0.260 |
Why?
|
| Skin Neoplasms | 4 | 2022 | 5863 | 0.250 |
Why?
|
| Acetylcysteine | 3 | 2011 | 262 | 0.250 |
Why?
|
| Drug Screening Assays, Antitumor | 6 | 2014 | 719 | 0.250 |
Why?
|
| Protein Transport | 7 | 2015 | 1951 | 0.250 |
Why?
|
| Galectin 3 | 1 | 2007 | 240 | 0.250 |
Why?
|
| Paclitaxel | 4 | 2019 | 1733 | 0.250 |
Why?
|
| Genes, p53 | 3 | 2007 | 714 | 0.250 |
Why?
|
| Carrier Proteins | 9 | 2014 | 4939 | 0.250 |
Why?
|
| RNA Processing, Post-Transcriptional | 5 | 1992 | 393 | 0.250 |
Why?
|
| DNA Topoisomerases, Type I | 6 | 1997 | 108 | 0.250 |
Why?
|
| Dose-Response Relationship, Drug | 31 | 2012 | 10763 | 0.250 |
Why?
|
| Serpins | 5 | 2003 | 246 | 0.250 |
Why?
|
| Globins | 6 | 1993 | 405 | 0.250 |
Why?
|
| G2 Phase | 5 | 2014 | 135 | 0.250 |
Why?
|
| Hybrid Cells | 3 | 2005 | 421 | 0.240 |
Why?
|
| Virulence Factors, Bordetella | 6 | 1992 | 154 | 0.240 |
Why?
|
| Prostate | 3 | 2023 | 1765 | 0.240 |
Why?
|
| Pertussis Toxin | 6 | 1992 | 176 | 0.240 |
Why?
|
| Protein Processing, Post-Translational | 7 | 2012 | 1966 | 0.240 |
Why?
|
| Clone Cells | 15 | 2010 | 1670 | 0.240 |
Why?
|
| Cyclic AMP | 6 | 1992 | 1470 | 0.240 |
Why?
|
| Zinc Fingers | 7 | 2001 | 577 | 0.240 |
Why?
|
| Antigens, CD | 6 | 2017 | 4035 | 0.240 |
Why?
|
| Cytosol | 5 | 2006 | 887 | 0.240 |
Why?
|
| Diterpenes | 8 | 1991 | 170 | 0.230 |
Why?
|
| Protein Isoforms | 2 | 2020 | 1715 | 0.230 |
Why?
|
| Adenoviruses, Human | 7 | 2004 | 257 | 0.230 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2005 | 229 | 0.230 |
Why?
|
| Histones | 4 | 2017 | 2601 | 0.230 |
Why?
|
| Arachidonic Acids | 6 | 1994 | 296 | 0.230 |
Why?
|
| CD8-Positive T-Lymphocytes | 8 | 2023 | 4648 | 0.230 |
Why?
|
| Glutathione Transferase | 6 | 2005 | 564 | 0.230 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 2 | 2017 | 210 | 0.230 |
Why?
|
| Dactinomycin | 10 | 1993 | 305 | 0.220 |
Why?
|
| Neoplastic Processes | 1 | 2023 | 36 | 0.220 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 10 | 2017 | 11878 | 0.220 |
Why?
|
| Nucleosomes | 5 | 1996 | 492 | 0.220 |
Why?
|
| RNA | 15 | 2000 | 2722 | 0.220 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2024 | 77 | 0.220 |
Why?
|
| Antineoplastic Agents, Phytogenic | 3 | 2005 | 622 | 0.220 |
Why?
|
| Fibroblasts | 9 | 2009 | 4178 | 0.220 |
Why?
|
| CA-125 Antigen | 1 | 2006 | 281 | 0.220 |
Why?
|
| Membrane Proteins | 8 | 2006 | 7876 | 0.220 |
Why?
|
| DNA Repair | 11 | 1998 | 2050 | 0.220 |
Why?
|
| Radiation-Sensitizing Agents | 6 | 2008 | 348 | 0.220 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2021 | 827 | 0.210 |
Why?
|
| Subcellular Fractions | 6 | 2007 | 525 | 0.210 |
Why?
|
| Cell Adhesion Molecules | 3 | 2001 | 1613 | 0.210 |
Why?
|
| Blotting, Western | 6 | 2015 | 5028 | 0.210 |
Why?
|
| Telomerase | 2 | 2016 | 751 | 0.210 |
Why?
|
| Lymphocyte Culture Test, Mixed | 8 | 2005 | 510 | 0.210 |
Why?
|
| Cell Nucleolus | 1 | 2003 | 156 | 0.210 |
Why?
|
| Imidazoles | 3 | 2007 | 1169 | 0.210 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2023 | 94 | 0.210 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 627 | 0.210 |
Why?
|
| Cytochromes c | 3 | 2012 | 173 | 0.210 |
Why?
|
| Pyrrolidinones | 2 | 2014 | 116 | 0.210 |
Why?
|
| Ubiquitin | 3 | 2011 | 843 | 0.210 |
Why?
|
| Butyrates | 3 | 1992 | 167 | 0.200 |
Why?
|
| Membrane Potentials | 5 | 2004 | 1090 | 0.200 |
Why?
|
| Platelet-Derived Growth Factor | 6 | 1996 | 617 | 0.200 |
Why?
|
| Cyclins | 5 | 2001 | 606 | 0.200 |
Why?
|
| Nanoparticles | 3 | 2020 | 1986 | 0.200 |
Why?
|
| Chromatin | 3 | 2023 | 2981 | 0.200 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2016 | 450 | 0.200 |
Why?
|
| Transcription Factor AP-1 | 2 | 2023 | 321 | 0.200 |
Why?
|
| Karyopherins | 2 | 2014 | 134 | 0.200 |
Why?
|
| Genes | 6 | 1989 | 1824 | 0.200 |
Why?
|
| Male | 77 | 2023 | 364731 | 0.200 |
Why?
|
| Genes, Regulator | 2 | 1994 | 373 | 0.200 |
Why?
|
| Cell Cycle Proteins | 5 | 2007 | 3445 | 0.200 |
Why?
|
| Computational Biology | 3 | 2021 | 3567 | 0.200 |
Why?
|
| Glutathione Peroxidase | 1 | 2003 | 259 | 0.200 |
Why?
|
| Simplexvirus | 5 | 1995 | 805 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2023 | 5704 | 0.200 |
Why?
|
| Active Transport, Cell Nucleus | 5 | 2011 | 432 | 0.190 |
Why?
|
| Cyclophosphamide | 6 | 2005 | 2227 | 0.190 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2020 | 507 | 0.190 |
Why?
|
| Floxuridine | 5 | 1986 | 44 | 0.190 |
Why?
|
| Enzyme Inhibitors | 10 | 2006 | 3728 | 0.190 |
Why?
|
| Taxoids | 1 | 2005 | 667 | 0.190 |
Why?
|
| Receptors, Interferon | 1 | 2022 | 115 | 0.190 |
Why?
|
| Mitosis | 2 | 2006 | 1178 | 0.190 |
Why?
|
| Vincristine | 2 | 1995 | 1040 | 0.190 |
Why?
|
| Lymphoma | 15 | 2012 | 1898 | 0.190 |
Why?
|
| Luciferases | 4 | 2011 | 713 | 0.190 |
Why?
|
| Phorbols | 3 | 1985 | 44 | 0.190 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2006 | 1730 | 0.190 |
Why?
|
| Oncogene Proteins v-abl | 2 | 1998 | 19 | 0.190 |
Why?
|
| Molecular Chaperones | 2 | 2006 | 762 | 0.190 |
Why?
|
| Arginine | 1 | 2005 | 932 | 0.190 |
Why?
|
| Infusions, Intravenous | 13 | 2003 | 2230 | 0.190 |
Why?
|
| Antineoplastic Agents, Alkylating | 4 | 2007 | 614 | 0.190 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2001 | 147 | 0.180 |
Why?
|
| Cell Membrane | 11 | 2012 | 3655 | 0.180 |
Why?
|
| Autophagy | 1 | 2009 | 1351 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-fos | 10 | 1993 | 580 | 0.180 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2021 | 85 | 0.180 |
Why?
|
| Vaccinia virus | 2 | 2000 | 328 | 0.180 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2021 | 69 | 0.180 |
Why?
|
| Isoquinolines | 8 | 2001 | 354 | 0.180 |
Why?
|
| Evolution, Molecular | 2 | 2007 | 1896 | 0.180 |
Why?
|
| Genes, fos | 6 | 1994 | 176 | 0.180 |
Why?
|
| K562 Cells | 3 | 2010 | 644 | 0.180 |
Why?
|
| Cell Adhesion | 10 | 2004 | 3097 | 0.180 |
Why?
|
| Immunization | 4 | 2011 | 1219 | 0.180 |
Why?
|
| Drug Evaluation | 14 | 1990 | 642 | 0.180 |
Why?
|
| Adenosine | 7 | 1988 | 822 | 0.180 |
Why?
|
| 3T3 Cells | 7 | 2001 | 1084 | 0.180 |
Why?
|
| Antigens, CD34 | 4 | 2016 | 657 | 0.180 |
Why?
|
| Nucleic Acid Hybridization | 23 | 1991 | 1305 | 0.180 |
Why?
|
| Hydroxyurea | 4 | 1985 | 284 | 0.180 |
Why?
|
| Virus Replication | 8 | 2003 | 2458 | 0.180 |
Why?
|
| Rats | 21 | 2011 | 23782 | 0.180 |
Why?
|
| Coculture Techniques | 5 | 2017 | 1344 | 0.170 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1628 | 0.170 |
Why?
|
| DNA, Complementary | 7 | 2002 | 1989 | 0.170 |
Why?
|
| RNA Interference | 3 | 2014 | 2832 | 0.170 |
Why?
|
| Immunoglobulin G | 8 | 2011 | 4568 | 0.170 |
Why?
|
| Phosphonoacetic Acid | 5 | 1982 | 54 | 0.170 |
Why?
|
| GTP Phosphohydrolases | 3 | 1995 | 525 | 0.170 |
Why?
|
| Transplantation, Heterologous | 18 | 2010 | 2393 | 0.170 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 664 | 0.170 |
Why?
|
| POU Domain Factors | 1 | 2020 | 47 | 0.170 |
Why?
|
| Antigens, Nuclear | 2 | 1997 | 183 | 0.170 |
Why?
|
| Immunization, Passive | 2 | 2002 | 619 | 0.170 |
Why?
|
| Ketone Oxidoreductases | 2 | 1990 | 5 | 0.170 |
Why?
|
| Gene Transfer Techniques | 5 | 2004 | 1207 | 0.170 |
Why?
|
| Synaptophysin | 1 | 2020 | 138 | 0.170 |
Why?
|
| X-Rays | 11 | 1995 | 311 | 0.170 |
Why?
|
| Collagen | 4 | 2002 | 2645 | 0.170 |
Why?
|
| Milk, Human | 5 | 1989 | 490 | 0.170 |
Why?
|
| Mice, Transgenic | 8 | 2017 | 9561 | 0.160 |
Why?
|
| IMP Dehydrogenase | 2 | 1990 | 34 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2017 | 1854 | 0.160 |
Why?
|
| Deoxyadenosines | 5 | 1985 | 27 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 4 | 2001 | 121 | 0.160 |
Why?
|
| HL-60 Cells | 5 | 2005 | 364 | 0.160 |
Why?
|
| Phosphotyrosine | 4 | 2011 | 458 | 0.160 |
Why?
|
| Aminopyridines | 2 | 2014 | 580 | 0.160 |
Why?
|
| Interferons | 1 | 2023 | 720 | 0.160 |
Why?
|
| Acetamides | 6 | 1992 | 259 | 0.160 |
Why?
|
| Genes, Immediate-Early | 4 | 1995 | 102 | 0.160 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2020 | 221 | 0.160 |
Why?
|
| DNA Polymerase I | 2 | 1989 | 44 | 0.160 |
Why?
|
| Prodrugs | 4 | 2001 | 274 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 23 | 2019 | 22380 | 0.160 |
Why?
|
| Intracellular Membranes | 4 | 2004 | 388 | 0.160 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 8 | 1994 | 221 | 0.160 |
Why?
|
| Myelodysplastic Syndromes | 4 | 1994 | 1399 | 0.160 |
Why?
|
| Kidney Neoplasms | 4 | 2012 | 4282 | 0.150 |
Why?
|
| Organophosphorus Compounds | 5 | 1982 | 211 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 1999 | 225 | 0.150 |
Why?
|
| Antigens, Surface | 8 | 2003 | 1617 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2014 | 859 | 0.150 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2013 | 494 | 0.150 |
Why?
|
| Hematopoietic Stem Cells | 9 | 2002 | 3409 | 0.150 |
Why?
|
| Tumor Stem Cell Assay | 6 | 2003 | 116 | 0.150 |
Why?
|
| RNA, Untranslated | 1 | 2022 | 455 | 0.150 |
Why?
|
| Ataxia Telangiectasia | 2 | 1997 | 107 | 0.150 |
Why?
|
| Models, Biological | 10 | 2021 | 9497 | 0.150 |
Why?
|
| Ligands | 3 | 2023 | 3284 | 0.150 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2012 | 1816 | 0.150 |
Why?
|
| Transplantation Immunology | 1 | 2000 | 537 | 0.150 |
Why?
|
| G1 Phase | 3 | 1999 | 403 | 0.150 |
Why?
|
| Coformycin | 3 | 1983 | 11 | 0.150 |
Why?
|
| Immunologic Factors | 3 | 2020 | 1596 | 0.150 |
Why?
|
| Phospholipases A2 | 8 | 1994 | 197 | 0.150 |
Why?
|
| Isoantigens | 1 | 2000 | 562 | 0.150 |
Why?
|
| Okadaic Acid | 6 | 1994 | 67 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 3 | 2002 | 71 | 0.140 |
Why?
|
| Methylation | 3 | 2017 | 1078 | 0.140 |
Why?
|
| Drug Resistance, Multiple | 2 | 1998 | 255 | 0.140 |
Why?
|
| Mitogens | 4 | 2010 | 229 | 0.140 |
Why?
|
| Mitomycin | 2 | 1996 | 261 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 6 | 2015 | 6082 | 0.140 |
Why?
|
| Glucose | 1 | 2009 | 4352 | 0.140 |
Why?
|
| Aspartic Acid | 5 | 1982 | 577 | 0.140 |
Why?
|
| Cell Communication | 3 | 2017 | 1660 | 0.140 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2023 | 1361 | 0.140 |
Why?
|
| Genes, Reporter | 5 | 2008 | 1524 | 0.140 |
Why?
|
| Benzamides | 6 | 2007 | 1379 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 12 | 2005 | 4058 | 0.140 |
Why?
|
| Wnt Proteins | 2 | 2016 | 725 | 0.140 |
Why?
|
| Gliosarcoma | 5 | 1998 | 115 | 0.140 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1999 | 631 | 0.140 |
Why?
|
| GTP-Binding Proteins | 3 | 1990 | 948 | 0.130 |
Why?
|
| Leukemia, Lymphoid | 4 | 1986 | 311 | 0.130 |
Why?
|
| Urologic Neoplasms | 1 | 2020 | 314 | 0.130 |
Why?
|
| GRB2 Adaptor Protein | 5 | 1995 | 101 | 0.130 |
Why?
|
| Lymphokines | 4 | 2002 | 925 | 0.130 |
Why?
|
| Luminescent Proteins | 3 | 2011 | 838 | 0.130 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2016 | 24 | 0.130 |
Why?
|
| Bone Marrow Cells | 6 | 2004 | 2414 | 0.130 |
Why?
|
| Killer Cells, Natural | 2 | 2023 | 2211 | 0.130 |
Why?
|
| Interleukin-6 | 7 | 2011 | 3229 | 0.130 |
Why?
|
| Vaccination | 7 | 2021 | 3437 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2013 | 5717 | 0.130 |
Why?
|
| Enzyme Precursors | 3 | 2000 | 166 | 0.130 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2016 | 103 | 0.130 |
Why?
|
| Meiosis | 1 | 1998 | 326 | 0.130 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 1996 | 663 | 0.130 |
Why?
|
| Cyclin D2 | 1 | 2016 | 98 | 0.130 |
Why?
|
| Granulocytes | 6 | 1990 | 551 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2003 | 2474 | 0.130 |
Why?
|
| Infusions, Parenteral | 11 | 1985 | 396 | 0.130 |
Why?
|
| Helminth Proteins | 1 | 1996 | 173 | 0.130 |
Why?
|
| Antigen Presentation | 6 | 2010 | 1251 | 0.130 |
Why?
|
| Aphidicolin | 8 | 1991 | 37 | 0.130 |
Why?
|
| Oligodeoxyribonucleotides | 6 | 1996 | 705 | 0.130 |
Why?
|
| Epidermal Growth Factor | 2 | 2012 | 697 | 0.130 |
Why?
|
| Receptors, Cell Surface | 7 | 1991 | 2819 | 0.130 |
Why?
|
| Ifosfamide | 1 | 1996 | 233 | 0.130 |
Why?
|
| Osteosarcoma | 2 | 2001 | 911 | 0.130 |
Why?
|
| DNA Primers | 5 | 2003 | 2828 | 0.120 |
Why?
|
| Catalytic Domain | 3 | 2003 | 699 | 0.120 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2016 | 125 | 0.120 |
Why?
|
| Neoplasm Metastasis | 11 | 2010 | 4913 | 0.120 |
Why?
|
| Melanoma, Experimental | 4 | 2008 | 559 | 0.120 |
Why?
|
| Ethanol | 2 | 1993 | 1331 | 0.120 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2014 | 466 | 0.120 |
Why?
|
| Cell Polarity | 2 | 2016 | 639 | 0.120 |
Why?
|
| Immunohistochemistry | 11 | 2016 | 11095 | 0.120 |
Why?
|
| Combined Modality Therapy | 23 | 2005 | 8542 | 0.120 |
Why?
|
| Cesium Radioisotopes | 4 | 1998 | 38 | 0.120 |
Why?
|
| Gadolinium | 1 | 2020 | 964 | 0.120 |
Why?
|
| Ganciclovir | 2 | 1998 | 256 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 8 | 2004 | 2631 | 0.120 |
Why?
|
| Cell Compartmentation | 4 | 2001 | 383 | 0.120 |
Why?
|
| Cloning, Molecular | 8 | 2004 | 4168 | 0.120 |
Why?
|
| Staurosporine | 4 | 2010 | 241 | 0.120 |
Why?
|
| Ornithine | 5 | 1985 | 79 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 12 | 2015 | 1703 | 0.120 |
Why?
|
| Remission Induction | 4 | 2016 | 2410 | 0.120 |
Why?
|
| Nucleoside Deaminases | 3 | 1997 | 58 | 0.120 |
Why?
|
| Endothelial Growth Factors | 3 | 2002 | 672 | 0.120 |
Why?
|
| Oxadiazoles | 1 | 2014 | 94 | 0.120 |
Why?
|
| 14-3-3 Proteins | 2 | 2006 | 221 | 0.120 |
Why?
|
| Adenosine Triphosphate | 3 | 2011 | 2004 | 0.120 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 7 | 2003 | 138 | 0.120 |
Why?
|
| Bleomycin | 3 | 2011 | 493 | 0.120 |
Why?
|
| Substrate Specificity | 5 | 2001 | 1751 | 0.120 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 1993 | 327 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1793 | 0.120 |
Why?
|
| Calmodulin | 2 | 2014 | 241 | 0.120 |
Why?
|
| Ceramides | 5 | 2000 | 203 | 0.120 |
Why?
|
| HMGA2 Protein | 1 | 2014 | 101 | 0.110 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2014 | 381 | 0.110 |
Why?
|
| Radiation Injuries, Experimental | 1 | 1994 | 88 | 0.110 |
Why?
|
| Type C Phospholipases | 3 | 1990 | 287 | 0.110 |
Why?
|
| Protein Stability | 1 | 2016 | 579 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 2 | 2023 | 2463 | 0.110 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 3 | 1985 | 109 | 0.110 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 6 | 1993 | 56 | 0.110 |
Why?
|
| Drug Delivery Systems | 4 | 2018 | 2237 | 0.110 |
Why?
|
| Cell Lineage | 2 | 2004 | 2575 | 0.110 |
Why?
|
| Time Factors | 23 | 2007 | 40220 | 0.110 |
Why?
|
| Tritium | 16 | 1985 | 707 | 0.110 |
Why?
|
| Phosphatidylcholines | 2 | 1992 | 406 | 0.110 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 2 | 1992 | 38 | 0.110 |
Why?
|
| Drug Compounding | 1 | 2015 | 242 | 0.110 |
Why?
|
| Cell Line, Transformed | 6 | 2002 | 866 | 0.110 |
Why?
|
| Polyamines | 2 | 1984 | 133 | 0.110 |
Why?
|
| COS Cells | 3 | 2000 | 1135 | 0.110 |
Why?
|
| Carcinoma, Lewis Lung | 5 | 2002 | 108 | 0.110 |
Why?
|
| Genes, myc | 2 | 1991 | 391 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1143 | 0.110 |
Why?
|
| Retinal Dehydrogenase | 1 | 2013 | 78 | 0.110 |
Why?
|
| Cullin Proteins | 1 | 2014 | 180 | 0.110 |
Why?
|
| Phospholipases | 2 | 1990 | 75 | 0.110 |
Why?
|
| Endothelium, Vascular | 11 | 2002 | 4428 | 0.110 |
Why?
|
| Ubiquitin-Activating Enzymes | 2 | 2014 | 85 | 0.110 |
Why?
|
| Purine Nucleosides | 2 | 2003 | 30 | 0.110 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1996 | 423 | 0.110 |
Why?
|
| Tretinoin | 4 | 2005 | 525 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 710 | 0.110 |
Why?
|
| Iodine Radioisotopes | 5 | 1995 | 1034 | 0.110 |
Why?
|
| Arachidonic Acid | 6 | 1994 | 429 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 1999 | 224 | 0.110 |
Why?
|
| Plasmids | 6 | 2005 | 2269 | 0.110 |
Why?
|
| Dacarbazine | 2 | 2007 | 552 | 0.110 |
Why?
|
| Blast Crisis | 2 | 1990 | 102 | 0.110 |
Why?
|
| Cyclin E | 1 | 2013 | 156 | 0.100 |
Why?
|
| Binding, Competitive | 5 | 2001 | 1142 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2000 | 693 | 0.100 |
Why?
|
| Dose-Response Relationship, Radiation | 10 | 2004 | 876 | 0.100 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2014 | 331 | 0.100 |
Why?
|
| Single-Cell Analysis | 2 | 2023 | 2540 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2040 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2010 | 1057 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 1247 | 0.100 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1992 | 98 | 0.100 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 7 | 1996 | 1437 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 317 | 0.100 |
Why?
|
| Colony-Forming Units Assay | 5 | 1999 | 351 | 0.100 |
Why?
|
| Point Mutation | 2 | 1996 | 1596 | 0.100 |
Why?
|
| Reducing Agents | 1 | 2011 | 13 | 0.100 |
Why?
|
| Isopropyl Thiogalactoside | 1 | 2011 | 11 | 0.100 |
Why?
|
| Zidovudine | 2 | 1992 | 625 | 0.100 |
Why?
|
| Cell Growth Processes | 2 | 2010 | 381 | 0.100 |
Why?
|
| Medical Oncology | 2 | 2023 | 2346 | 0.100 |
Why?
|
| Antigen-Antibody Reactions | 2 | 2011 | 342 | 0.100 |
Why?
|
| Estradiol | 2 | 2012 | 1951 | 0.100 |
Why?
|
| beta-Galactosidase | 6 | 1999 | 575 | 0.100 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 2011 | 355 | 0.100 |
Why?
|
| Ubiquitination | 1 | 2016 | 1009 | 0.100 |
Why?
|
| Triterpenes | 1 | 2012 | 78 | 0.100 |
Why?
|
| Aerobiosis | 1 | 2011 | 100 | 0.100 |
Why?
|
| Tumor Burden | 2 | 2015 | 1906 | 0.100 |
Why?
|
| Retroviridae | 7 | 2019 | 846 | 0.100 |
Why?
|
| Cardiolipins | 1 | 2011 | 83 | 0.100 |
Why?
|
| S Phase | 1 | 1993 | 424 | 0.100 |
Why?
|
| Actins | 8 | 2000 | 2064 | 0.100 |
Why?
|
| Adult | 59 | 2023 | 223646 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2023 | 9419 | 0.090 |
Why?
|
| Phenotype | 13 | 2011 | 16726 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 8 | 2014 | 2634 | 0.090 |
Why?
|
| Apigenin | 1 | 2011 | 16 | 0.090 |
Why?
|
| Hemoglobins | 5 | 1989 | 1531 | 0.090 |
Why?
|
| Radioimmunoassay | 8 | 1992 | 863 | 0.090 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2011 | 37 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 3806 | 0.090 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 3 | 2001 | 306 | 0.090 |
Why?
|
| Interleukin-3 | 3 | 1999 | 425 | 0.090 |
Why?
|
| DNA Fragmentation | 3 | 2000 | 240 | 0.090 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2012 | 164 | 0.090 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 1972 | 0.090 |
Why?
|
| Stromal Cells | 1 | 2017 | 1337 | 0.090 |
Why?
|
| Milk Proteins | 3 | 1988 | 161 | 0.090 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2012 | 3187 | 0.090 |
Why?
|
| Transduction, Genetic | 6 | 2012 | 899 | 0.090 |
Why?
|
| Heme | 4 | 1986 | 316 | 0.090 |
Why?
|
| Hematologic Neoplasms | 2 | 2016 | 1907 | 0.090 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2012 | 148 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2014 | 705 | 0.090 |
Why?
|
| Theophylline | 2 | 1993 | 133 | 0.090 |
Why?
|
| Vidarabine Phosphate | 2 | 1989 | 11 | 0.090 |
Why?
|
| Middle Aged | 57 | 2016 | 223487 | 0.090 |
Why?
|
| Guanosine Triphosphate | 2 | 1988 | 315 | 0.090 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1990 | 74 | 0.090 |
Why?
|
| Carcinogens | 3 | 2001 | 453 | 0.090 |
Why?
|
| Epitope Mapping | 1 | 2011 | 301 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2016 | 3115 | 0.090 |
Why?
|
| Phenanthridines | 3 | 2000 | 50 | 0.090 |
Why?
|
| Polymers | 1 | 2018 | 1630 | 0.090 |
Why?
|
| BRCA1 Protein | 1 | 2017 | 1155 | 0.090 |
Why?
|
| Antibodies, Neoplasm | 4 | 2003 | 283 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases | 4 | 1995 | 203 | 0.090 |
Why?
|
| Oxazoles | 2 | 1982 | 199 | 0.090 |
Why?
|
| Hybridomas | 1 | 2011 | 444 | 0.090 |
Why?
|
| Cytokines | 12 | 2017 | 7452 | 0.090 |
Why?
|
| Tissue Fixation | 1 | 2011 | 245 | 0.090 |
Why?
|
| Genes, APC | 2 | 2004 | 145 | 0.090 |
Why?
|
| Gene Regulatory Networks | 2 | 2009 | 1752 | 0.090 |
Why?
|
| Mammary Neoplasms, Experimental | 6 | 2003 | 506 | 0.090 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1994 | 1367 | 0.090 |
Why?
|
| Consensus Sequence | 1 | 2011 | 363 | 0.090 |
Why?
|
| Bucladesine | 2 | 1990 | 118 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2020 | 2062 | 0.090 |
Why?
|
| Isoxazoles | 2 | 1982 | 233 | 0.090 |
Why?
|
| Glycogen Synthase Kinases | 2 | 2001 | 40 | 0.090 |
Why?
|
| Guanine Nucleotides | 1 | 1990 | 55 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2008 | 257 | 0.090 |
Why?
|
| Ricin | 1 | 1990 | 70 | 0.090 |
Why?
|
| Antigens, Differentiation | 2 | 2010 | 921 | 0.090 |
Why?
|
| DNA, Viral | 11 | 1999 | 2204 | 0.090 |
Why?
|
| Immune Tolerance | 2 | 2000 | 2323 | 0.090 |
Why?
|
| Erythropoietin | 1 | 1994 | 718 | 0.090 |
Why?
|
| Glycine | 2 | 2005 | 672 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2011 | 488 | 0.080 |
Why?
|
| Macromolecular Substances | 5 | 1997 | 1435 | 0.080 |
Why?
|
| RNA, Ribosomal | 4 | 1984 | 227 | 0.080 |
Why?
|
| Myelopoiesis | 1 | 2010 | 135 | 0.080 |
Why?
|
| Etoposide | 1 | 1991 | 639 | 0.080 |
Why?
|
| Models, Molecular | 2 | 2018 | 5402 | 0.080 |
Why?
|
| Lactones | 2 | 1991 | 316 | 0.080 |
Why?
|
| Alkylating Agents | 2 | 1994 | 132 | 0.080 |
Why?
|
| Deoxycytidine | 2 | 1986 | 887 | 0.080 |
Why?
|
| Methotrexate | 5 | 1982 | 1721 | 0.080 |
Why?
|
| Biological Transport | 3 | 2001 | 2085 | 0.080 |
Why?
|
| Rauscher Virus | 10 | 1974 | 13 | 0.080 |
Why?
|
| Oligonucleotides | 2 | 2008 | 563 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2004 | 681 | 0.080 |
Why?
|
| Ubiquitins | 2 | 2014 | 366 | 0.080 |
Why?
|
| Burkitt Lymphoma | 6 | 1975 | 338 | 0.080 |
Why?
|
| X-Ray Therapy | 1 | 2008 | 8 | 0.080 |
Why?
|
| CREB-Binding Protein | 2 | 1999 | 147 | 0.080 |
Why?
|
| Phylogeny | 2 | 2007 | 2843 | 0.080 |
Why?
|
| Cytotoxicity Tests, Immunologic | 4 | 2005 | 317 | 0.080 |
Why?
|
| Aged | 44 | 2016 | 171502 | 0.080 |
Why?
|
| Defective Viruses | 3 | 2002 | 89 | 0.080 |
Why?
|
| Cricetinae | 2 | 2007 | 2423 | 0.080 |
Why?
|
| Sequence Deletion | 3 | 2003 | 1497 | 0.080 |
Why?
|
| Thionucleosides | 2 | 1985 | 13 | 0.080 |
Why?
|
| Phenylisopropyladenosine | 1 | 1988 | 14 | 0.080 |
Why?
|
| Biopolymers | 1 | 2009 | 183 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2004 | 2748 | 0.080 |
Why?
|
| Eflornithine | 5 | 1985 | 31 | 0.080 |
Why?
|
| Keratinocytes | 1 | 1993 | 876 | 0.080 |
Why?
|
| Jurkat Cells | 3 | 2007 | 740 | 0.080 |
Why?
|
| Granzymes | 1 | 2010 | 277 | 0.080 |
Why?
|
| Gene Amplification | 2 | 2008 | 1095 | 0.080 |
Why?
|
| Mammary Glands, Human | 1 | 2009 | 202 | 0.080 |
Why?
|
| Lipopolysaccharides | 3 | 1992 | 2222 | 0.080 |
Why?
|
| Biotin | 2 | 2008 | 256 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2001 | 379 | 0.070 |
Why?
|
| Melphalan | 2 | 2008 | 421 | 0.070 |
Why?
|
| Glycosylation | 2 | 2007 | 1100 | 0.070 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2007 | 56 | 0.070 |
Why?
|
| Mice, Knockout | 6 | 2010 | 14488 | 0.070 |
Why?
|
| Caspase 1 | 2 | 2000 | 227 | 0.070 |
Why?
|
| Inhibitor of Apoptosis Proteins | 3 | 1999 | 200 | 0.070 |
Why?
|
| Dinoprostone | 4 | 1992 | 597 | 0.070 |
Why?
|
| Transplantation, Autologous | 4 | 2013 | 2125 | 0.070 |
Why?
|
| RNA, Viral | 17 | 1976 | 2874 | 0.070 |
Why?
|
| Oncogenic Viruses | 8 | 1975 | 37 | 0.070 |
Why?
|
| alpha Karyopherins | 1 | 2007 | 42 | 0.070 |
Why?
|
| Asparagine | 1 | 2007 | 120 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 7 | 1989 | 1535 | 0.070 |
Why?
|
| Botulinum Toxins | 1 | 1989 | 191 | 0.070 |
Why?
|
| Flucytosine | 2 | 1997 | 31 | 0.070 |
Why?
|
| Stomach | 1 | 2011 | 701 | 0.070 |
Why?
|
| beta Karyopherins | 1 | 2007 | 46 | 0.070 |
Why?
|
| Endostatins | 3 | 2002 | 167 | 0.070 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1991 | 925 | 0.070 |
Why?
|
| Methylthioinosine | 2 | 1984 | 4 | 0.070 |
Why?
|
| Arabinonucleotides | 1 | 1986 | 5 | 0.070 |
Why?
|
| Centrifugation, Density Gradient | 12 | 1985 | 298 | 0.070 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2006 | 53 | 0.070 |
Why?
|
| Sialoglycoproteins | 1 | 1988 | 320 | 0.070 |
Why?
|
| Alkalies | 2 | 1983 | 45 | 0.070 |
Why?
|
| Arabinofuranosylcytosine Triphosphate | 4 | 1988 | 7 | 0.070 |
Why?
|
| Drug Administration Schedule | 9 | 2012 | 4861 | 0.070 |
Why?
|
| Quinazolines | 1 | 2013 | 1373 | 0.070 |
Why?
|
| Mucin-5B | 1 | 2007 | 148 | 0.070 |
Why?
|
| Hematopoiesis | 3 | 1992 | 2059 | 0.070 |
Why?
|
| Mice, SCID | 4 | 2015 | 2627 | 0.070 |
Why?
|
| Sodium | 2 | 1990 | 1597 | 0.070 |
Why?
|
| Angiostatins | 6 | 2002 | 64 | 0.070 |
Why?
|
| Oligosaccharides | 1 | 1989 | 407 | 0.070 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2006 | 81 | 0.070 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2007 | 146 | 0.070 |
Why?
|
| Brain Neoplasms | 8 | 2004 | 9118 | 0.070 |
Why?
|
| Mucin-4 | 1 | 2006 | 33 | 0.070 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2006 | 42 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 6525 | 0.070 |
Why?
|
| Acetophenones | 3 | 1990 | 52 | 0.070 |
Why?
|
| Tubercidin | 1 | 1985 | 14 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2002 | 749 | 0.070 |
Why?
|
| Models, Genetic | 2 | 2007 | 3447 | 0.070 |
Why?
|
| Estrogens | 1 | 2013 | 1536 | 0.070 |
Why?
|
| Guanine | 1 | 2007 | 280 | 0.060 |
Why?
|
| Benzoquinones | 1 | 2006 | 198 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 1996 | 185 | 0.060 |
Why?
|
| Microtubules | 2 | 2006 | 1064 | 0.060 |
Why?
|
| Alkynes | 1 | 2007 | 326 | 0.060 |
Why?
|
| Histocytochemistry | 3 | 2000 | 699 | 0.060 |
Why?
|
| Th17 Cells | 1 | 2012 | 791 | 0.060 |
Why?
|
| DNA, Single-Stranded | 2 | 2001 | 351 | 0.060 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 597 | 0.060 |
Why?
|
| Cricetulus | 1 | 2007 | 812 | 0.060 |
Why?
|
| Maximum Tolerated Dose | 4 | 2012 | 899 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 4 | 2008 | 588 | 0.060 |
Why?
|
| Antioxidants | 2 | 2004 | 1676 | 0.060 |
Why?
|
| DNA Polymerase II | 2 | 1984 | 103 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2010 | 4415 | 0.060 |
Why?
|
| Inositol Phosphates | 3 | 1990 | 175 | 0.060 |
Why?
|
| Virus Activation | 2 | 2019 | 324 | 0.060 |
Why?
|
| DNA Repair Enzymes | 1 | 2007 | 343 | 0.060 |
Why?
|
| DNA-Activated Protein Kinase | 4 | 1998 | 111 | 0.060 |
Why?
|
| RNA Stability | 1 | 2007 | 320 | 0.060 |
Why?
|
| Sarcoma | 9 | 2004 | 1806 | 0.060 |
Why?
|
| Eosinophils | 1 | 1990 | 952 | 0.060 |
Why?
|
| Repressor Proteins | 2 | 1993 | 2982 | 0.060 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 1994 | 792 | 0.060 |
Why?
|
| Gamma Rays | 3 | 1997 | 319 | 0.060 |
Why?
|
| Putrescine | 4 | 1986 | 42 | 0.060 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2004 | 49 | 0.060 |
Why?
|
| Spermine | 4 | 1986 | 70 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-raf | 3 | 1994 | 205 | 0.060 |
Why?
|
| Ultraviolet Rays | 4 | 1996 | 1103 | 0.060 |
Why?
|
| Nucleic Acid Precursors | 1 | 1984 | 16 | 0.060 |
Why?
|
| Lactams, Macrocyclic | 1 | 2006 | 319 | 0.060 |
Why?
|
| Arsenicals | 1 | 2005 | 117 | 0.060 |
Why?
|
| CHO Cells | 1 | 2007 | 1379 | 0.060 |
Why?
|
| Cell Transplantation | 2 | 2003 | 475 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 3620 | 0.060 |
Why?
|
| Escherichia coli | 5 | 2011 | 4213 | 0.060 |
Why?
|
| Drug Design | 1 | 2009 | 1046 | 0.060 |
Why?
|
| Glioma | 4 | 2004 | 3503 | 0.060 |
Why?
|
| Disease Models, Animal | 10 | 2019 | 18349 | 0.060 |
Why?
|
| Ionomycin | 1 | 2004 | 110 | 0.060 |
Why?
|
| Transgenes | 2 | 1998 | 1016 | 0.060 |
Why?
|
| Ionophores | 1 | 2004 | 108 | 0.060 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2004 | 46 | 0.060 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2004 | 69 | 0.060 |
Why?
|
| DNA, Recombinant | 2 | 2000 | 455 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 505 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 1074 | 0.060 |
Why?
|
| Carcinogenicity Tests | 1 | 2003 | 39 | 0.060 |
Why?
|
| Histone Acetyltransferases | 1 | 2006 | 335 | 0.060 |
Why?
|
| Butyric Acid | 3 | 1992 | 52 | 0.060 |
Why?
|
| gamma Catenin | 1 | 2003 | 45 | 0.060 |
Why?
|
| Cross Reactions | 4 | 1986 | 828 | 0.060 |
Why?
|
| Cell Culture Techniques | 3 | 2004 | 1667 | 0.060 |
Why?
|
| Methyl Methanesulfonate | 3 | 2000 | 28 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 3 | 2005 | 2065 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2006 | 394 | 0.050 |
Why?
|
| Hypersensitivity, Delayed | 2 | 2005 | 491 | 0.050 |
Why?
|
| Carboxylesterase | 3 | 1991 | 31 | 0.050 |
Why?
|
| Vaccines, Synthetic | 2 | 1997 | 622 | 0.050 |
Why?
|
| Desmoplakins | 1 | 2003 | 63 | 0.050 |
Why?
|
| Oxides | 1 | 2005 | 403 | 0.050 |
Why?
|
| Creatinine | 2 | 2002 | 1918 | 0.050 |
Why?
|
| Adenine | 1 | 2009 | 995 | 0.050 |
Why?
|
| Alkaloids | 5 | 2000 | 192 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 3 | 2000 | 83 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2003 | 219 | 0.050 |
Why?
|
| Inosine | 1 | 1984 | 129 | 0.050 |
Why?
|
| Phytohemagglutinins | 2 | 2000 | 165 | 0.050 |
Why?
|
| Carboxylic Ester Hydrolases | 3 | 1991 | 99 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2007 | 1512 | 0.050 |
Why?
|
| Mycosis Fungoides | 2 | 1981 | 169 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2000 | 185 | 0.050 |
Why?
|
| Calcitriol | 3 | 1991 | 303 | 0.050 |
Why?
|
| Lipoproteins | 1 | 1988 | 880 | 0.050 |
Why?
|
| Uracil | 1 | 1984 | 210 | 0.050 |
Why?
|
| Drug Interactions | 3 | 2002 | 1419 | 0.050 |
Why?
|
| HIV-1 | 4 | 1996 | 6963 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 1754 | 0.050 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 195 | 0.050 |
Why?
|
| Restriction Mapping | 3 | 1994 | 849 | 0.050 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2003 | 86 | 0.050 |
Why?
|
| Heat-Shock Proteins | 2 | 2000 | 797 | 0.050 |
Why?
|
| Ketoconazole | 2 | 1994 | 95 | 0.050 |
Why?
|
| RNA-Directed DNA Polymerase | 8 | 1991 | 223 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2004 | 669 | 0.050 |
Why?
|
| Th1-Th2 Balance | 2 | 2012 | 38 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 1984 | 242 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 2 | 2012 | 1625 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2004 | 2334 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2011 | 1319 | 0.050 |
Why?
|
| Nucleosides | 1 | 1982 | 130 | 0.050 |
Why?
|
| Antimetabolites | 1 | 1982 | 128 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2002 | 2300 | 0.050 |
Why?
|
| Adenosine Deaminase Inhibitors | 1 | 1981 | 9 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 2 | 2005 | 999 | 0.050 |
Why?
|
| Lymphocytes | 3 | 1997 | 2614 | 0.050 |
Why?
|
| STAT Transcription Factors | 2 | 2012 | 189 | 0.050 |
Why?
|
| Sphingosine | 2 | 2001 | 308 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2006 | 2202 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2000 | 474 | 0.050 |
Why?
|
| Plasmacytoma | 1 | 2002 | 170 | 0.050 |
Why?
|
| Diglycerides | 2 | 1993 | 176 | 0.050 |
Why?
|
| Intercalating Agents | 1 | 2001 | 33 | 0.050 |
Why?
|
| Leukocyte Count | 6 | 2000 | 1609 | 0.050 |
Why?
|
| Catenins | 1 | 2001 | 44 | 0.050 |
Why?
|
| Cell Separation | 2 | 2004 | 1728 | 0.050 |
Why?
|
| Genes, abl | 1 | 2001 | 69 | 0.050 |
Why?
|
| Rats, Inbred F344 | 6 | 1998 | 826 | 0.050 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2001 | 112 | 0.050 |
Why?
|
| Prognosis | 8 | 2009 | 30009 | 0.050 |
Why?
|
| Quinacrine | 2 | 1990 | 24 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2000 | 9 | 0.050 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2000 | 14 | 0.050 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2000 | 68 | 0.050 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 5 | 1993 | 934 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2002 | 228 | 0.040 |
Why?
|
| Rad51 Recombinase | 2 | 1999 | 191 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2000 | 81 | 0.040 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2000 | 61 | 0.040 |
Why?
|
| CD4-CD8 Ratio | 1 | 2000 | 114 | 0.040 |
Why?
|
| Fever | 3 | 2005 | 1614 | 0.040 |
Why?
|
| Hydrolysis | 2 | 1992 | 646 | 0.040 |
Why?
|
| Epithelium | 4 | 1988 | 1607 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 1904 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 1141 | 0.040 |
Why?
|
| Viruses | 2 | 2001 | 373 | 0.040 |
Why?
|
| Antibody Formation | 2 | 2002 | 1393 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2002 | 594 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12543 | 0.040 |
Why?
|
| Bryostatins | 2 | 1991 | 24 | 0.040 |
Why?
|
| RNA Caps | 1 | 2000 | 73 | 0.040 |
Why?
|
| Umbilical Veins | 4 | 2001 | 425 | 0.040 |
Why?
|
| Hodgkin Disease | 9 | 1992 | 1384 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2001 | 235 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 463 | 0.040 |
Why?
|
| Mice, Inbred NOD | 2 | 2015 | 1837 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 1990 | 82 | 0.040 |
Why?
|
| Esophageal Neoplasms | 4 | 2003 | 1668 | 0.040 |
Why?
|
| Homeostasis | 1 | 2011 | 3348 | 0.040 |
Why?
|
| RNA, Catalytic | 1 | 1999 | 52 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2000 | 3814 | 0.040 |
Why?
|
| Fibrosarcoma | 2 | 1999 | 313 | 0.040 |
Why?
|
| Adenosine Diphosphate Ribose | 2 | 1990 | 70 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2002 | 596 | 0.040 |
Why?
|
| Oleic Acids | 3 | 2000 | 71 | 0.040 |
Why?
|
| Herpesviridae | 2 | 1997 | 104 | 0.040 |
Why?
|
| Mice, Inbred C3H | 5 | 2005 | 915 | 0.040 |
Why?
|
| Basement Membrane | 1 | 2000 | 348 | 0.040 |
Why?
|
| Receptors, Vitronectin | 1 | 1998 | 48 | 0.040 |
Why?
|
| Son of Sevenless Proteins | 2 | 1995 | 27 | 0.040 |
Why?
|
| Antibody Specificity | 3 | 1992 | 1065 | 0.040 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 1988 | 87 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2004 | 979 | 0.040 |
Why?
|
| Thionucleotides | 2 | 1988 | 107 | 0.040 |
Why?
|
| Glioblastoma | 4 | 2004 | 3464 | 0.040 |
Why?
|
| Erythrocytes | 1 | 1988 | 2418 | 0.040 |
Why?
|
| Macrolides | 2 | 1991 | 205 | 0.040 |
Why?
|
| RNA Viruses | 6 | 1975 | 112 | 0.040 |
Why?
|
| Mammary Tumor Virus, Mouse | 8 | 1977 | 41 | 0.040 |
Why?
|
| Idoxuridine | 1 | 1998 | 111 | 0.040 |
Why?
|
| ADP Ribose Transferases | 1 | 1998 | 90 | 0.040 |
Why?
|
| Spermatocytes | 1 | 1998 | 40 | 0.040 |
Why?
|
| Antibodies, Bispecific | 1 | 2001 | 204 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2021 | 547 | 0.040 |
Why?
|
| Staining and Labeling | 3 | 1998 | 1080 | 0.040 |
Why?
|
| Amides | 1 | 2001 | 452 | 0.040 |
Why?
|
| Exotoxins | 1 | 1998 | 123 | 0.040 |
Why?
|
| Leukocytes | 3 | 1984 | 2034 | 0.040 |
Why?
|
| Skin Tests | 1 | 2000 | 639 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1998 | 455 | 0.040 |
Why?
|
| Androstadienes | 2 | 2000 | 348 | 0.040 |
Why?
|
| Erythropoiesis | 3 | 1988 | 691 | 0.040 |
Why?
|
| Pentostatin | 3 | 1983 | 26 | 0.040 |
Why?
|
| Pokeweed Mitogens | 2 | 1994 | 38 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2005 | 1377 | 0.040 |
Why?
|
| Polyethylene Glycols | 3 | 2014 | 1197 | 0.040 |
Why?
|
| Laryngeal Neoplasms | 3 | 1997 | 514 | 0.040 |
Why?
|
| Colloids | 1 | 1998 | 125 | 0.040 |
Why?
|
| Tachycardia | 1 | 2000 | 599 | 0.040 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 1998 | 139 | 0.040 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 274 | 0.040 |
Why?
|
| Growth Substances | 3 | 1993 | 760 | 0.040 |
Why?
|
| Choline | 2 | 1990 | 522 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 1997 | 435 | 0.040 |
Why?
|
| Brain Diseases | 1 | 1986 | 1554 | 0.040 |
Why?
|
| Drug Therapy, Combination | 7 | 1995 | 6316 | 0.040 |
Why?
|
| Protease Inhibitors | 2 | 2002 | 751 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3703 | 0.040 |
Why?
|
| Antibodies | 2 | 2008 | 2421 | 0.040 |
Why?
|
| Treatment Outcome | 8 | 2016 | 65379 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 2004 | 4363 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 2010 | 3049 | 0.030 |
Why?
|
| Herpesvirus 8, Human | 1 | 1999 | 256 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2023 | 1105 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2000 | 855 | 0.030 |
Why?
|
| Bone Marrow Purging | 1 | 1996 | 108 | 0.030 |
Why?
|
| Templates, Genetic | 5 | 1985 | 188 | 0.030 |
Why?
|
| Immunity | 2 | 2000 | 1003 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 1998 | 260 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 1998 | 274 | 0.030 |
Why?
|
| Growth Inhibitors | 2 | 2002 | 375 | 0.030 |
Why?
|
| Water | 1 | 2003 | 1421 | 0.030 |
Why?
|
| Platelet Factor 4 | 1 | 1997 | 132 | 0.030 |
Why?
|
| Receptors, CCR7 | 2 | 2008 | 105 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2B1 | 1 | 1996 | 22 | 0.030 |
Why?
|
| Deoxycytidine Kinase | 1 | 1996 | 11 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2002 | 3517 | 0.030 |
Why?
|
| Janus Kinase 2 | 2 | 2017 | 561 | 0.030 |
Why?
|
| Metyrapone | 1 | 1996 | 22 | 0.030 |
Why?
|
| Delayed-Action Preparations | 2 | 2014 | 969 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2020 | 2195 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 1997 | 182 | 0.030 |
Why?
|
| Stimulation, Chemical | 2 | 1993 | 305 | 0.030 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2004 | 957 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 1997 | 478 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2001 | 1680 | 0.030 |
Why?
|
| Neuraminidase | 2 | 1987 | 195 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 1998 | 1525 | 0.030 |
Why?
|
| HIV Long Terminal Repeat | 1 | 1996 | 86 | 0.030 |
Why?
|
| Macrophages | 4 | 1987 | 5802 | 0.030 |
Why?
|
| Vitamin D | 1 | 2010 | 3311 | 0.030 |
Why?
|
| Mitomycins | 1 | 1995 | 46 | 0.030 |
Why?
|
| Anisomycin | 1 | 1995 | 27 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 2000 | 753 | 0.030 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 1995 | 34 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 15453 | 0.030 |
Why?
|
| Endopeptidases | 2 | 1997 | 764 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 3 | 2005 | 411 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2000 | 1228 | 0.030 |
Why?
|
| Chromosomes | 2 | 1998 | 578 | 0.030 |
Why?
|
| Deoxycytosine Nucleotides | 2 | 1988 | 13 | 0.030 |
Why?
|
| Genes, Viral | 1 | 1997 | 655 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1999 | 1156 | 0.030 |
Why?
|
| Thymine Nucleotides | 3 | 1990 | 57 | 0.030 |
Why?
|
| Radioimmunodetection | 1 | 1995 | 45 | 0.030 |
Why?
|
| Injections, Intravenous | 3 | 1995 | 1379 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 2 | 2006 | 4413 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1998 | 1683 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2001 | 1133 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 1999 | 671 | 0.030 |
Why?
|
| Carcinoma, Small Cell | 3 | 1995 | 419 | 0.030 |
Why?
|
| Albumins | 1 | 2018 | 577 | 0.030 |
Why?
|
| Bone Marrow Examination | 2 | 1993 | 154 | 0.030 |
Why?
|
| Ribonuclease III | 1 | 2017 | 271 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 3 | 1986 | 446 | 0.030 |
Why?
|
| Herpesvirus 1, Human | 1 | 2001 | 743 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 1995 | 120 | 0.030 |
Why?
|
| Cell Count | 2 | 1994 | 1832 | 0.030 |
Why?
|
| Virulence Factors | 1 | 1998 | 502 | 0.030 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 1995 | 183 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2006 | 4786 | 0.030 |
Why?
|
| Oxygen | 1 | 2006 | 4270 | 0.030 |
Why?
|
| Spleen | 6 | 2004 | 2296 | 0.030 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 1994 | 93 | 0.030 |
Why?
|
| Dynamins | 1 | 1995 | 141 | 0.030 |
Why?
|
| Benzophenanthridines | 3 | 2000 | 27 | 0.030 |
Why?
|
| Daunorubicin | 1 | 1994 | 157 | 0.030 |
Why?
|
| Immunosuppressive Agents | 2 | 2023 | 4206 | 0.030 |
Why?
|
| Thrombocytopenia | 4 | 2001 | 1179 | 0.030 |
Why?
|
| Cyclopentanes | 1 | 2014 | 87 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1758 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2000 | 1676 | 0.030 |
Why?
|
| Gammaretrovirus | 2 | 1973 | 24 | 0.030 |
Why?
|
| Propylene Glycols | 1 | 2014 | 91 | 0.030 |
Why?
|
| Depsipeptides | 1 | 1994 | 96 | 0.030 |
Why?
|
| HLA-DR Antigens | 3 | 1999 | 609 | 0.030 |
Why?
|
| Verapamil | 1 | 1994 | 242 | 0.030 |
Why?
|
| Telomere | 1 | 2000 | 943 | 0.030 |
Why?
|
| Drug Combinations | 3 | 2000 | 2089 | 0.030 |
Why?
|
| Chickens | 4 | 1993 | 845 | 0.030 |
Why?
|
| Ribosomal Protein S6 | 1 | 1993 | 70 | 0.030 |
Why?
|
| Activating Transcription Factor 2 | 1 | 1993 | 44 | 0.030 |
Why?
|
| Stomach Neoplasms | 2 | 2003 | 1481 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1994 | 203 | 0.030 |
Why?
|
| Half-Life | 2 | 1986 | 651 | 0.030 |
Why?
|
| Serum Response Factor | 1 | 1993 | 78 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 1994 | 213 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 2 | 1984 | 100 | 0.030 |
Why?
|
| Radiation Genetics | 1 | 1993 | 16 | 0.030 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 1991 | 178 | 0.030 |
Why?
|
| Clinical Trials as Topic | 4 | 2006 | 8052 | 0.030 |
Why?
|
| Lung Diseases | 2 | 1997 | 1944 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2002 | 8142 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1997 | 1134 | 0.030 |
Why?
|
| Leucine Zippers | 1 | 1993 | 116 | 0.030 |
Why?
|
| Radionuclide Imaging | 3 | 1988 | 2000 | 0.030 |
Why?
|
| Lactates | 1 | 2014 | 401 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2017 | 549 | 0.030 |
Why?
|
| Liposomes | 1 | 1997 | 792 | 0.030 |
Why?
|
| Recurrence | 2 | 2009 | 8509 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 378 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 1995 | 605 | 0.030 |
Why?
|
| Craniocerebral Trauma | 1 | 1997 | 493 | 0.030 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 1993 | 88 | 0.030 |
Why?
|
| Ditiocarb | 1 | 1992 | 6 | 0.030 |
Why?
|
| Fowlpox virus | 1 | 2012 | 21 | 0.030 |
Why?
|
| Astrocytoma | 1 | 1997 | 774 | 0.030 |
Why?
|
| Aged, 80 and over | 8 | 2012 | 59626 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 1998 | 922 | 0.030 |
Why?
|
| Monokines | 1 | 1992 | 71 | 0.030 |
Why?
|
| Ascitic Fluid | 2 | 1984 | 189 | 0.030 |
Why?
|
| Protein Conformation | 2 | 1991 | 3956 | 0.030 |
Why?
|
| Chemokine CCL4 | 1 | 1992 | 127 | 0.030 |
Why?
|
| Cell-Free System | 3 | 2000 | 339 | 0.030 |
Why?
|
| Gene Conversion | 1 | 1992 | 69 | 0.030 |
Why?
|
| Dinoprost | 1 | 1992 | 139 | 0.030 |
Why?
|
| Lymph Nodes | 2 | 2002 | 3474 | 0.030 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1992 | 122 | 0.030 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2012 | 57 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1992 | 4620 | 0.030 |
Why?
|
| Pyrimidine Nucleosides | 1 | 1991 | 7 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 2568 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1992 | 81 | 0.020 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1992 | 58 | 0.020 |
Why?
|
| Intestinal Mucosa | 2 | 1981 | 3044 | 0.020 |
Why?
|
| Gene Library | 2 | 1997 | 1064 | 0.020 |
Why?
|
| Teratoma | 1 | 1995 | 405 | 0.020 |
Why?
|
| Codon | 1 | 1994 | 599 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 1993 | 228 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 1992 | 194 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 1992 | 260 | 0.020 |
Why?
|
| Electrophoresis | 1 | 1992 | 226 | 0.020 |
Why?
|
| Receptors, Lipoprotein | 1 | 1992 | 88 | 0.020 |
Why?
|
| Interleukin-1 | 2 | 1992 | 1252 | 0.020 |
Why?
|
| Peroxidases | 1 | 1992 | 135 | 0.020 |
Why?
|
| Reference Values | 2 | 1997 | 4939 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1995 | 572 | 0.020 |
Why?
|
| Calcium Chloride | 1 | 2011 | 79 | 0.020 |
Why?
|
| Microbial Collagenase | 1 | 1992 | 112 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2014 | 610 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2012 | 151 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2016 | 1015 | 0.020 |
Why?
|
| Thioinosine | 1 | 1990 | 4 | 0.020 |
Why?
|
| Lentivirus | 1 | 2014 | 518 | 0.020 |
Why?
|
| Niacinamide | 1 | 1993 | 418 | 0.020 |
Why?
|
| Endocytosis | 2 | 2003 | 957 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 1995 | 839 | 0.020 |
Why?
|
| Digestive System | 2 | 1982 | 244 | 0.020 |
Why?
|
| Immune System | 1 | 2016 | 800 | 0.020 |
Why?
|
| Interleukin-10 | 2 | 2008 | 1184 | 0.020 |
Why?
|
| Dideoxynucleotides | 1 | 1990 | 13 | 0.020 |
Why?
|
| Ribosomal Proteins | 1 | 1993 | 369 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 306 | 0.020 |
Why?
|
| Regression Analysis | 2 | 1999 | 6340 | 0.020 |
Why?
|
| Oncogene Protein p65(gag-jun) | 1 | 1990 | 7 | 0.020 |
Why?
|
| DNA Adducts | 1 | 2011 | 95 | 0.020 |
Why?
|
| Mice, Inbred Strains | 3 | 1991 | 1769 | 0.020 |
Why?
|
| Janus Kinases | 1 | 2012 | 253 | 0.020 |
Why?
|
| Apoptotic Protease-Activating Factor 1 | 2 | 2000 | 21 | 0.020 |
Why?
|
| Schistosoma | 1 | 1990 | 17 | 0.020 |
Why?
|
| Interferon Type I | 2 | 1985 | 569 | 0.020 |
Why?
|
| Lysophosphatidylcholines | 1 | 1990 | 77 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2011 | 113 | 0.020 |
Why?
|
| Receptors, Colony-Stimulating Factor | 2 | 1988 | 51 | 0.020 |
Why?
|
| Platelet Count | 2 | 1992 | 787 | 0.020 |
Why?
|
| Collagen Type XVIII | 2 | 2000 | 52 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1993 | 500 | 0.020 |
Why?
|
| Melitten | 1 | 1990 | 13 | 0.020 |
Why?
|
| Stem Cells | 1 | 1983 | 3538 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1992 | 309 | 0.020 |
Why?
|
| Thymine | 2 | 1981 | 69 | 0.020 |
Why?
|
| Naphthol AS D Esterase | 1 | 1990 | 14 | 0.020 |
Why?
|
| Stearic Acids | 1 | 1990 | 56 | 0.020 |
Why?
|
| Adenylate Cyclase Toxin | 1 | 1990 | 25 | 0.020 |
Why?
|
| Coma | 2 | 1986 | 485 | 0.020 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1990 | 53 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1987 | 2486 | 0.020 |
Why?
|
| Oleic Acid | 1 | 1990 | 91 | 0.020 |
Why?
|
| DNA Probes | 1 | 1991 | 542 | 0.020 |
Why?
|
| Peptide Initiation Factors | 2 | 2000 | 53 | 0.020 |
Why?
|
| Melanoma | 3 | 2012 | 5706 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1981 | 1662 | 0.020 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1973 | 290 | 0.020 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2010 | 70 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1988 | 766 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1991 | 513 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1606 | 0.020 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1990 | 221 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1996 | 880 | 0.020 |
Why?
|
| Particle Size | 1 | 2014 | 1651 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 1991 | 739 | 0.020 |
Why?
|
| Cell Movement | 4 | 2002 | 5213 | 0.020 |
Why?
|
| Deoxyadenine Nucleotides | 1 | 1989 | 14 | 0.020 |
Why?
|
| Polymorphism, Genetic | 2 | 1992 | 4249 | 0.020 |
Why?
|
| Survival Rate | 3 | 2010 | 12840 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1989 | 417 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2010 | 251 | 0.020 |
Why?
|
| Avian leukosis virus | 6 | 1978 | 18 | 0.020 |
Why?
|
| Sialomucins | 1 | 1989 | 18 | 0.020 |
Why?
|
| Body Weight | 2 | 2000 | 4627 | 0.020 |
Why?
|
| Culture Media, Conditioned | 2 | 2002 | 521 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 1990 | 252 | 0.020 |
Why?
|
| Injections, Subcutaneous | 2 | 2000 | 687 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 1995 | 714 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 1 | 1990 | 286 | 0.020 |
Why?
|
| Permeability | 2 | 2002 | 726 | 0.020 |
Why?
|
| Neoplasm Staging | 3 | 1997 | 11244 | 0.020 |
Why?
|
| Laminin | 2 | 2000 | 405 | 0.020 |
Why?
|
| Lysosomes | 1 | 2014 | 938 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1989 | 293 | 0.020 |
Why?
|
| Calibration | 1 | 1991 | 819 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 1991 | 542 | 0.020 |
Why?
|
| Carbohydrate Sequence | 1 | 1989 | 411 | 0.020 |
Why?
|
| Friend murine leukemia virus | 1 | 1988 | 37 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2010 | 315 | 0.020 |
Why?
|
| Ethanolamines | 2 | 2000 | 152 | 0.020 |
Why?
|
| Syndrome | 2 | 1985 | 3273 | 0.020 |
Why?
|
| Corynebacterium | 1 | 1968 | 49 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2010 | 349 | 0.020 |
Why?
|
| Arabinofuranosyluracil | 1 | 1987 | 10 | 0.020 |
Why?
|
| Endocannabinoids | 2 | 2000 | 113 | 0.020 |
Why?
|
| Replicon | 1 | 1987 | 35 | 0.020 |
Why?
|
| Exocytosis | 1 | 1989 | 323 | 0.020 |
Why?
|
| Area Under Curve | 2 | 2003 | 1643 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1987 | 174 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 1999 | 5315 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1992 | 1055 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1989 | 640 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 1990 | 562 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2007 | 114 | 0.020 |
Why?
|
| Proteoglycans | 2 | 2000 | 809 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 2521 | 0.020 |
Why?
|
| Tetrahydrouridine | 1 | 1986 | 5 | 0.020 |
Why?
|
| Catalysis | 2 | 2000 | 768 | 0.020 |
Why?
|
| Histiocytes | 1 | 1987 | 97 | 0.020 |
Why?
|
| Deoxyuridine | 1 | 1986 | 34 | 0.020 |
Why?
|
| Cytosine Deaminase | 2 | 1997 | 63 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1988 | 254 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2008 | 348 | 0.020 |
Why?
|
| Phospholipids | 1 | 1990 | 787 | 0.020 |
Why?
|
| Marek Disease | 2 | 1978 | 3 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1992 | 2204 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 1997 | 20225 | 0.020 |
Why?
|
| Adenosylmethionine Decarboxylase | 1 | 1985 | 11 | 0.020 |
Why?
|
| Bone Marrow Diseases | 1 | 1988 | 234 | 0.020 |
Why?
|
| Boston | 2 | 1996 | 9374 | 0.020 |
Why?
|
| Rosette Formation | 1 | 1985 | 152 | 0.020 |
Why?
|
| Genes, MDR | 1 | 2005 | 36 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 1992 | 1394 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1988 | 480 | 0.020 |
Why?
|
| S-Adenosylhomocysteine | 1 | 1985 | 40 | 0.020 |
Why?
|
| Carbohydrate Conformation | 1 | 1985 | 206 | 0.020 |
Why?
|
| Tumor Necrosis Factors | 1 | 2005 | 109 | 0.020 |
Why?
|
| Quinoxalines | 1 | 2007 | 297 | 0.020 |
Why?
|
| Furans | 1 | 2007 | 202 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 1968 | 501 | 0.020 |
Why?
|
| Colon | 1 | 1993 | 1801 | 0.020 |
Why?
|
| Collodion | 1 | 1985 | 34 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1987 | 387 | 0.020 |
Why?
|
| Apolipoproteins E | 2 | 1992 | 1461 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 1987 | 556 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1985 | 71 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1993 | 2914 | 0.020 |
Why?
|
| Paper | 1 | 1985 | 83 | 0.020 |
Why?
|
| Colitis | 1 | 1993 | 1242 | 0.020 |
Why?
|
| B-Lymphocytes | 2 | 1997 | 4793 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 4120 | 0.010 |
Why?
|
| Acidosis | 1 | 1986 | 271 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1985 | 363 | 0.010 |
Why?
|
| Phosphoribosyl Pyrophosphate | 1 | 1984 | 5 | 0.010 |
Why?
|
| Adenofibroma | 1 | 1984 | 25 | 0.010 |
Why?
|
| S-Adenosylmethionine | 1 | 1985 | 219 | 0.010 |
Why?
|
| Interleukins | 1 | 1989 | 796 | 0.010 |
Why?
|
| Breast Diseases | 1 | 1987 | 442 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1983 | 1627 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 1986 | 358 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1984 | 175 | 0.010 |
Why?
|
| Chemistry | 1 | 1983 | 327 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 1988 | 498 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1990 | 1880 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1983 | 486 | 0.010 |
Why?
|
| Sarcoma, Experimental | 2 | 1996 | 117 | 0.010 |
Why?
|
| Chromosome Aberrations | 3 | 1987 | 1778 | 0.010 |
Why?
|
| Fibrocystic Breast Disease | 1 | 1984 | 103 | 0.010 |
Why?
|
| RecQ Helicases | 1 | 2003 | 53 | 0.010 |
Why?
|
| Methionine | 1 | 1986 | 573 | 0.010 |
Why?
|
| Interphase | 1 | 1983 | 227 | 0.010 |
Why?
|
| RNA Precursors | 1 | 1984 | 196 | 0.010 |
Why?
|
| Karyotyping | 1 | 1985 | 1177 | 0.010 |
Why?
|
| Diazepam | 1 | 1984 | 214 | 0.010 |
Why?
|
| Aorta | 2 | 2002 | 2045 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1987 | 594 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1982 | 186 | 0.010 |
Why?
|
| Autoanalysis | 1 | 1982 | 70 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1983 | 406 | 0.010 |
Why?
|
| Blindness | 1 | 1986 | 587 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 188 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1984 | 428 | 0.010 |
Why?
|
| Culture Media | 1 | 1984 | 898 | 0.010 |
Why?
|
| Comet Assay | 1 | 2002 | 74 | 0.010 |
Why?
|
| Hypotension | 1 | 1988 | 888 | 0.010 |
Why?
|
| Exodeoxyribonucleases | 1 | 2003 | 191 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 652 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 1990 | 1205 | 0.010 |
Why?
|
| Deoxyribonucleosides | 1 | 1981 | 7 | 0.010 |
Why?
|
| Orotic Acid | 1 | 1981 | 24 | 0.010 |
Why?
|
| Adenosine Kinase | 1 | 1981 | 13 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1992 | 2697 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 412 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1997 | 14729 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 2002 | 199 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2001 | 110 | 0.010 |
Why?
|
| Adolescent | 9 | 1992 | 89169 | 0.010 |
Why?
|
| Pentanoic Acids | 1 | 1981 | 19 | 0.010 |
Why?
|
| Caffeine | 1 | 1986 | 703 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2005 | 996 | 0.010 |
Why?
|
| Pregnancy | 4 | 1989 | 30255 | 0.010 |
Why?
|
| Calcium | 1 | 1994 | 5792 | 0.010 |
Why?
|
| Iron | 1 | 1989 | 1813 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 945 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1984 | 830 | 0.010 |
Why?
|
| Genes, erbB-2 | 1 | 2001 | 162 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1982 | 567 | 0.010 |
Why?
|
| Bronchitis | 1 | 1981 | 194 | 0.010 |
Why?
|
| Pichia | 1 | 2000 | 49 | 0.010 |
Why?
|
| Thymidine Phosphorylase | 1 | 1980 | 16 | 0.010 |
Why?
|
| Arrestin | 1 | 2000 | 30 | 0.010 |
Why?
|
| Cell Migration Inhibition | 1 | 2000 | 97 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 1981 | 302 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1980 | 133 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1980 | 84 | 0.010 |
Why?
|
| Genital Neoplasms, Female | 1 | 1985 | 536 | 0.010 |
Why?
|
| Menopause | 1 | 1988 | 1656 | 0.010 |
Why?
|
| Conjunctivitis | 1 | 1981 | 153 | 0.010 |
Why?
|
| Biological Availability | 1 | 1981 | 391 | 0.010 |
Why?
|
| Pedigree | 1 | 1988 | 4539 | 0.010 |
Why?
|
| HLA Antigens | 2 | 1987 | 1334 | 0.010 |
Why?
|
| Biotransformation | 1 | 2000 | 166 | 0.010 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2000 | 111 | 0.010 |
Why?
|
| Cholesterol | 1 | 2009 | 2914 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1986 | 1309 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2002 | 462 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2000 | 112 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2002 | 825 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1982 | 481 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1980 | 192 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 2000 | 525 | 0.010 |
Why?
|
| Adenovirus E2 Proteins | 1 | 1998 | 8 | 0.010 |
Why?
|
| Nervous System | 1 | 1982 | 544 | 0.010 |
Why?
|
| Lac Operon | 1 | 1999 | 237 | 0.010 |
Why?
|
| Cyclohexenes | 1 | 1998 | 15 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2004 | 1042 | 0.010 |
Why?
|
| Extremities | 1 | 2004 | 870 | 0.010 |
Why?
|
| DNA Nucleotidyltransferases | 3 | 1974 | 177 | 0.010 |
Why?
|
| Genes, Retinoblastoma | 1 | 1999 | 125 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 1999 | 280 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2002 | 1587 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2012 | 2360 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2002 | 747 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2004 | 1078 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 1986 | 2709 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2004 | 36741 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2002 | 634 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 6847 | 0.010 |
Why?
|
| Tetracycline | 1 | 1999 | 216 | 0.010 |
Why?
|
| Avian Leukosis | 1 | 1978 | 1 | 0.010 |
Why?
|
| Herpesvirus 2, Gallid | 1 | 1978 | 1 | 0.010 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1998 | 134 | 0.010 |
Why?
|
| Random Allocation | 1 | 2003 | 2395 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 1985 | 1171 | 0.010 |
Why?
|
| Benzofurans | 1 | 1998 | 139 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1997 | 138 | 0.010 |
Why?
|
| Liver Diseases | 1 | 1986 | 1305 | 0.010 |
Why?
|
| Transcription Factor DP1 | 1 | 1997 | 136 | 0.010 |
Why?
|
| Lung | 1 | 2016 | 10101 | 0.010 |
Why?
|
| Dietary Fats | 1 | 1985 | 2003 | 0.010 |
Why?
|
| Ceramidases | 1 | 1997 | 4 | 0.010 |
Why?
|
| Forecasting | 1 | 1987 | 2945 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 1989 | 3858 | 0.010 |
Why?
|
| Macaca mulatta | 2 | 1982 | 2363 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1999 | 605 | 0.010 |
Why?
|
| E2F1 Transcription Factor | 1 | 1997 | 182 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22290 | 0.010 |
Why?
|
| HLA-DR7 Antigen | 1 | 1996 | 27 | 0.010 |
Why?
|
| Skin | 2 | 2005 | 4505 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 1997 | 270 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2003 | 1273 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 2001 | 553 | 0.010 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 1996 | 70 | 0.010 |
Why?
|
| Antigens, Viral | 2 | 1977 | 995 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 2122 | 0.010 |
Why?
|
| Zinc Sulfate | 1 | 1995 | 18 | 0.010 |
Why?
|
| Amidohydrolases | 1 | 1997 | 160 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2001 | 1179 | 0.010 |
Why?
|
| Mastadenovirus | 1 | 1995 | 1 | 0.010 |
Why?
|
| Zinc Compounds | 1 | 1995 | 36 | 0.010 |
Why?
|
| Oncostatin M | 1 | 1995 | 42 | 0.010 |
Why?
|
| DNA, Superhelical | 1 | 1996 | 51 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2008 | 3589 | 0.010 |
Why?
|
| Microcirculation | 1 | 2000 | 1281 | 0.010 |
Why?
|
| Neutropenia | 1 | 2001 | 892 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1999 | 841 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2001 | 1530 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2002 | 1370 | 0.010 |
Why?
|
| Receptors, Virus | 1 | 1998 | 651 | 0.010 |
Why?
|
| Carmustine | 1 | 1995 | 137 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1997 | 781 | 0.010 |
Why?
|
| Sulfates | 1 | 1995 | 379 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 3819 | 0.010 |
Why?
|
| Acute Disease | 1 | 1985 | 7243 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1994 | 166 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1989 | 13013 | 0.010 |
Why?
|
| Integrins | 1 | 1998 | 842 | 0.010 |
Why?
|
| Deoxyribonucleotides | 1 | 1973 | 43 | 0.010 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1973 | 76 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 1904 | 0.010 |
Why?
|
| Neutrophils | 2 | 2000 | 3786 | 0.010 |
Why?
|
| Survival Analysis | 2 | 1997 | 10099 | 0.010 |
Why?
|
| Mass Screening | 1 | 1989 | 5458 | 0.010 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1980 | 952 | 0.010 |
Why?
|
| Binding Sites, Antibody | 2 | 1988 | 340 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1996 | 960 | 0.010 |
Why?
|
| Sirolimus | 1 | 2000 | 1540 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1981 | 4034 | 0.010 |
Why?
|
| Hospitals, Municipal | 1 | 1992 | 19 | 0.010 |
Why?
|
| Chelating Agents | 1 | 1994 | 385 | 0.010 |
Why?
|
| Infectious Mononucleosis | 1 | 1973 | 133 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1994 | 361 | 0.010 |
Why?
|
| AIDS-Related Complex | 1 | 1992 | 107 | 0.010 |
Why?
|
| Linear Models | 1 | 2002 | 5884 | 0.010 |
Why?
|
| Scavenger Receptors, Class B | 1 | 1992 | 85 | 0.010 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 1992 | 67 | 0.010 |
Why?
|
| Receptors, Scavenger | 1 | 1992 | 123 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1996 | 2179 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 8741 | 0.010 |
Why?
|
| Kidney | 3 | 1984 | 7064 | 0.010 |
Why?
|
| Neurofibroma | 1 | 1972 | 95 | 0.010 |
Why?
|
| Virology | 1 | 1991 | 76 | 0.010 |
Why?
|
| Autoradiography | 1 | 1972 | 728 | 0.010 |
Why?
|
| Placenta | 1 | 2000 | 1725 | 0.010 |
Why?
|
| Axilla | 1 | 1993 | 623 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1981 | 2100 | 0.010 |
Why?
|
| Anemia | 1 | 2000 | 1514 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1992 | 392 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 1995 | 936 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1989 | 6873 | 0.010 |
Why?
|
| Ascites | 1 | 1991 | 338 | 0.010 |
Why?
|
| Liposarcoma | 1 | 1972 | 289 | 0.000 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1997 | 3556 | 0.000 |
Why?
|
| Rhabdomyosarcoma | 1 | 1972 | 358 | 0.000 |
Why?
|
| Diseases in Twins | 3 | 1975 | 447 | 0.000 |
Why?
|
| Genetics, Microbial | 1 | 1968 | 53 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1989 | 39354 | 0.000 |
Why?
|
| Leiomyosarcoma | 1 | 1972 | 426 | 0.000 |
Why?
|
| Algorithms | 1 | 1988 | 14164 | 0.000 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1992 | 530 | 0.000 |
Why?
|
| Mucous Membrane | 2 | 1981 | 659 | 0.000 |
Why?
|
| Keratins | 1 | 1988 | 499 | 0.000 |
Why?
|
| Isotope Labeling | 1 | 1988 | 394 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1997 | 2682 | 0.000 |
Why?
|
| Child | 3 | 1988 | 80917 | 0.000 |
Why?
|
| Receptors, Immunologic | 1 | 1992 | 1418 | 0.000 |
Why?
|
| Rabbits | 1 | 1992 | 4773 | 0.000 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1992 | 1494 | 0.000 |
Why?
|
| Manometry | 1 | 1968 | 459 | 0.000 |
Why?
|
| Young Adult | 1 | 2012 | 60066 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1981 | 6314 | 0.000 |
Why?
|
| Endotoxins | 1 | 1987 | 519 | 0.000 |
Why?
|
| Child, Preschool | 2 | 1988 | 42669 | 0.000 |
Why?
|
| Hyperplasia | 1 | 1987 | 1151 | 0.000 |
Why?
|
| Diarrhea | 2 | 1981 | 1320 | 0.000 |
Why?
|
| Leukemia Virus, Murine | 2 | 1974 | 95 | 0.000 |
Why?
|
| Attitude to Health | 1 | 1992 | 2025 | 0.000 |
Why?
|
| Adenoma | 1 | 1993 | 2159 | 0.000 |
Why?
|
| Carcinoma in Situ | 1 | 1987 | 788 | 0.000 |
Why?
|
| Colitis, Ulcerative | 1 | 1993 | 1926 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 2000 | 7477 | 0.000 |
Why?
|
| Species Specificity | 2 | 1977 | 2415 | 0.000 |
Why?
|
| Carboxypeptidases | 1 | 1981 | 121 | 0.000 |
Why?
|
| Injections, Intraventricular | 1 | 1981 | 227 | 0.000 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1981 | 64 | 0.000 |
Why?
|
| Infant | 1 | 1983 | 36535 | 0.000 |
Why?
|
| Precancerous Conditions | 1 | 1987 | 985 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 20762 | 0.000 |
Why?
|
| Leucovorin | 1 | 1981 | 643 | 0.000 |
Why?
|
| Breast | 1 | 1987 | 1976 | 0.000 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1978 | 152 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1982 | 1191 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1978 | 530 | 0.000 |
Why?
|
| Medulloblastoma | 1 | 1981 | 683 | 0.000 |
Why?
|
| Haplorhini | 1 | 1976 | 523 | 0.000 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 1973 | 1375 | 0.000 |
Why?
|
| Avian myeloblastosis virus | 1 | 1974 | 19 | 0.000 |
Why?
|
| Polyploidy | 1 | 1975 | 120 | 0.000 |
Why?
|
| Papio | 1 | 1976 | 671 | 0.000 |
Why?
|
| Urethane | 1 | 1973 | 38 | 0.000 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1973 | 45 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1973 | 636 | 0.000 |
Why?
|
| Ribonucleases | 1 | 1973 | 266 | 0.000 |
Why?
|
| Skin Diseases | 1 | 1980 | 1085 | 0.000 |
Why?
|
| Mammary Glands, Animal | 1 | 1973 | 273 | 0.000 |
Why?
|
| Epididymis | 1 | 1973 | 227 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 1992 | 26379 | 0.000 |
Why?
|
| Brain | 1 | 1997 | 27362 | 0.000 |
Why?
|
| Milk | 1 | 1972 | 438 | 0.000 |
Why?
|
| Ribosomes | 1 | 1972 | 497 | 0.000 |
Why?
|
| Thymus Gland | 1 | 1973 | 1266 | 0.000 |
Why?
|
| Fetus | 1 | 1972 | 1883 | 0.000 |
Why?
|
| Liver | 1 | 1973 | 7578 | 0.000 |
Why?
|
| Aging | 1 | 1973 | 8743 | 0.000 |
Why?
|